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INTRODUCTION

This study examines the effect of two human DNA viruses
on primary human cells.

Herpes simplex virus 2 (HSV-2) and

either human papillo~avirus type 16 or type 18 (HPV-16, HPV18)

DNA

was

intrGduced

into

human

cells

to

generate

transformed cell lines. Cell lines were established with two
human cell types:
in

vivo

by

fibroblasts

HPVs
are

keratinocytes, the naturally infected cell
and
not

HSV-2,

the

and

target

fibroblasts.

cell

of

HPVs,

Although
they were

utilized because of the availability of two cell strains:
normal primary gingival fibroblasts (N-16) and a hyperplastic
counterpart

(R-30).

It

has

been

hypothesized

that

transformation is a multistep phenomenon (reviewed in Bishop,
1985) .

The primary aim of this investigation was to determine

if HSV-2 and HPV-16/18 cooperate to morphologically transform
primary human cells.
Transfection of primary cells with HPV types 16 or 18 DNA
alone produces an immortalized cell.

These cells do not

produce tumors when heterotransplanted into immunosuppressed
mice

(Durst et al.,

1987, Pirisi et al.,

1987)

suggesting

progression to the malignant phenotype after HPV infection in
vivo requires additional cofactors.
1

HSV-2 is hypothesized to

2

cooperate with oncogenic HPVs to produce a malignant phenotype
{zur

Hausen,

immortalized

Keratinocyte

1982).
cell

lines

were

or

compared

fibroblast

with

HPV

respective

HPV/HSV-2 transformed cell lines in four major areas of study.
The

first

area

examined

was

growth

characteristics.

saturation density analysis and anchorage independent growth
studies demonstrated that transformed cells proliferated more
'
than. their
corresponding
efficiently
immortalized
counterparts.
The second area of study was to determine if viral DNA
was retained in the various cell lines.

HPV sequences are

present in 80-85% of cervical carcinoma biopsies {Broker and
Botchan, 1986, Durst et al., 1983) and are usually integrated
into the cellular genome with only a portion of the viral DNA
present {Durst et al.,

1985).

Transformed cell lines were

analyzed by Southern blot analysis to determine retention and
genomic organization of HPV DNA as well as to study the
physical state of HPV DNA.

Retention of HSV-2 DNA sequences

in transformed cells was examined by polymerase chain reaction
{PCR) analysis. Approximately 50% of the cell lines retained
HSV-2

DNA

sequences.

keratinocytes

with

Comparison

HPV-18/HSV-2

of

HPV

transformed

immortalized
keratinocytes

showed rearrangement of HPV DNA in the transformed cells in
contrast to the immortalized cell lines.
Integration of HPV-16 DNA into the cellular genome has
been shown to cause alterations of the c-myc protooncogene

3

(Rieu et al., 1987, Durst et al., 1987, Crook et al., 1990)
and organization of this gene in transformed cell lines was
analyzed.

Interactions of the tumor suppressor gene, p53, and

subsequent inactivation of this gene are associated with high
risk HPVs such as type 16 and 18
scheffner

et

al.,

1990).

To

(Werness et al.,

understand

what

role

1990,
this

cellular protooncoge~e and tumor suppressor gene have in the
morphological transf-0rmation of primary human cells was the
third aim of this study.
The final area of analysis was to examine the tumorigenic
potential of the immortalized and transformed cell lines.
Nude mice were injected subcutaneously with different cell
lines and examined for the production of palpable tumors.

LITERATURE REVIEW

Multistep phenomenon of transformation.

Morphological

transformation of primary cells is a multistep phenomenon
(reviewed in Bishop, ,1985, Stanbridge, 1990).

Many mechanisms

exist in the etiology of human malignancy, however, it is not
known what specific factors are required for progression.
Malignant tumors are thought to result from a series of events
which are cumulative with each subsequent event generating an
additional phenotypic alteration.

Genetic aberrations, due to

endogenous or exogenous stimulation, which extend cellular
lifespan,

can allow for overall genetic instability within

these cells (Meuth, 1990).
several factors are associated with instability leading
to progression.

Loss or gain of entire chromosomes can lead

to severe aneuploidy (German, 1983), a common characteristic
of cancer cells.
(Vogelstein

et

Large scale deletions within chromosomes
al.,

1989)

can

also

lead

to

loss

or

rearrangment of regulatory genes resulting in an increased
risk of mutation or gene amplification (reviewed in Meuth,
1990, Giulotto et al., 1987).
not

required,

hypothesized

rather
to

be

the

the

A specific order of events is

summation

primary
4

of

factor

these
in

events

is

carcinogenesis

5

(reviewed in Bishop, 1991).
Environmental and chemical mutagens, viral oncoproteins
and hereditary factors are associated with carcinogenesis.
several viruses have recently been correlated to the etiology
of human tumors: 1) hepatitis B virus associated with cancer
of the

liver

associated

(Wang et al.,

with

Burkitt's
1

1990),

2)

lymphoma

Epstein-Barr virus
and

nasopharyangeal

carcinomas (Raab-Traub et al., 1983, Fahreus et al., 1988), 3)
human

papillomaviruses

and

herpes

4)

simplex

virus

2

associated with genital carcinomas (Rawls et al., 1969, DiLuca
et al., 1989).
Cancer of the cervix is the second leading cancer in
women

(Parkin

et

al.,

1988).

Epidemiological

studies

of

precancerous lesions and invasive cervical carcinomas have
demonstrated a correlation between these lesions and sexually
transmitted disease (STD).

The major risk factors of cervical

carcinoma are the early age of intercourse and multiple sexual
partners

(Rotkin, 1973, Kessler,

1977).

The prevalence of

viral and viral-associated antigens as well as viral nucleic
acid

in many

anogenital

lesions

associated with

STD has

suggested human papillomaviruses (HPVs) are the etiological
agents of many of these STD lesions (Becker et al., 1987).
With approximately one sixth of all cancer deaths in females
due to cervical cancer,
understanding the

there is

significant interest in

pathogenesis of HPVs

(Parkin et al., 1988).

in genital

cancer

6

Classification of PVs.

The papillomaviruses (PVs) are a

group of small DNA viruses in the Papovaviridae (Ginsberg,
They typically induce proliferative lesions of the

1980).

skin and mucosal epithelia.

PV infections are widespread in

mammals affecting cattle, sheep, deer, dogs, monkeys, pigs or
man (Sundberg, 1987).

Classification is based on host range

with type categorization based on nucleic acid hybridization
1

studies.

Viral isolates are considered an independent type if

there is less than 50% homology with known isolates (Coggin
and zur Hausen, 1979).
PVs

are

etiological

agents

of

many

epithelial

Specific PV types are associated with specific

disorders.
disease

the

processes

carcinoma.

ranging

from

warts

to

human

cervical

Oncogenic activity of PVs was first described in

rabbits where cottontail rabbit papillomavirus (CRPV) induced
benign papillomas which later metastisized to lymph nodes and
lungs

(Rous

and

Beard,

1935).

Over

6 O types

papillomaviruses (HPV) have been identified.

of

human

Each HPV type

has site preferences for either cutaneous or mucosal squamous
epithelium where many can cause clinical lesions (Jenson et
al.,

1988).

Benign

proliferative

lesions

of

cutaneous

epithelium are referred to as warts whereas mucosal lesions
are called condylomas.
Approximately two thirds of HPVs infect skin while the
remaining

types

infect

keratinizing

and

nonkeratinizing

squamous epithelia of the anogenital tract or the oral mucosa

7

(Jenson et al.,

These mucosotrophic HPVs

1988) •

can be

classified with respect to oncogenic potential as either low,
intermediate, or high risk.

HPV-6 and -11 are found primarily

in genital condylomata (Gissman and zur Hausen, 1980, Gissman
et al.,

1983), rarely detected in cervical carcinomas, and

thus are regarded as low risk viruses.
are

found

in

appr~ximately

10%

HPV-31, -33, and -35

of

cervical

dysplasias,

primarily premalignant lesions (Lorincz et al., 1987, Fuchs et
al., 1988), and consequently classified as low or intermediate
risk types.

HPV-16 and -18 are associated with the majority

of invasive cervical carcinomas, the viral DNA can be detected
in 85% of cervical carcinoma biopsies (Broker and Botchan,
1986), and thus are regarded as high risk types (Yoshikawa et
al., 1985, Mccance et al., 1985).
Although the highest incidence of carcinomas associated
with HPV infections is in anogenital tissue, specific HPVs can
also infect other mucosal surfaces such as the orolaryngeal
and bronchial mucosa. HPV-6 and 11 are frequently detected in
benign laryngeal and bronchial papillomas (Gissmann et al.,
1982, Mounts et al., 1982, Ikenberg et al., 1985) while HPV-16
is

also

associated with

carcinonomas
buccal

mucosa

(Stremlau

et

some

orolaryngeal

(deVilliers et al.,
(Loning
al.,

et

1985).

al.,

1985),
1985)

tongue

carcinomas of the

and

However,

tumors,

lung

these

carcinomas

cancers

are

relatively infrequent compared to carcinoma of the cervix.
Growth characteristics of HPVs.

Specific phases of the

8

HPV

infection

cycle

are

epithelial keratinocytes.

restricted

to

differentiated

The infection cycle begins in the

proliferating basal layer of epithelial cells.

PV infection

appears to require physical contact of virus to basal cells.
The

cells

which

are

between

the

squamous

and

columnar

epithelium such as those in the nasal mucosa, the larynx, the
borders of healing wounds are called
'
transformation zones• (T-zones) and are especially susceptible
cervix,

and

at

to HPV infection.

These T-zones are a common target for HPV

infection

(reviewed

mechanism

of

expression

and

HPV

in

Broker

infection

viral

and

Botchan,

and

replication

1986).

subsequent
is

not

well

early

The
gene

understood

primarily because a cell culture system is not available.
Although it is possible to grow human keratinocytes in vitro,
the inability to differentiate these cells does not allow for
a complete infection cycle.

However, Kreider et al.,

(1985)

have developed a animal model system to produce an active HPV6 infection. Virus-infected cells are engrafted beneath the
renal capsule of mice resulting in the production of putative
precancerous lesions.
these lesions.

Virus particles can be isolated from

Viral replication occurs in the basal cells

since in squamous epithelium, keratinocytes only proliferate
in the basal layer.
a

sequence

of

When cells leave this layer, they undergo

biochemical

and

phenotypic

constitutes terminal differentiation.

changes

which

Ultimately, these cells

are sloughed off as fully differentiated cells (reviewed in

9

Eckert, 1989).

Viral DNA synthesis has been detected by in

situ hybridization studies in the stratum spinosum

(spiny

layer) as well as the stratum granulosum (granular layer) of
the epidermis (Wagner et al., 1984).
PVs

appears

to

be

closely

Thus the lifecycle of

linked

to

the

state

of

differentiation of squamous epithelial cells (reviewed in Orth
et al., 1977).
Latent HPV infections represent the largest reservoir for
mucosotrophic HPV infections
Latently

infected

tissue

(Jenson and Lancaster,

does

not

exhibit

any

1990).
unusual

morphology compared to normal squamous epithelium (MacNab et
al., 1986) and viral DNA can be detected only by Southern or
dot blot analysis of infected tissue.
induces

the

latent

infection

to

It is not known what

become

active

although

mechanical or chemical trauma and infection of regenerating
squamous cells may lead to recurrence (Ferenczy et al., 1985).
Molecular

characteristics

of

HPV.

The

genome

of

papillomaviruses consists of a circular double stranded DNA
molecule of approximately 8 kilobase pairs (kbp).
DNA

is

complexed

with

histones

and

molecular weight of 4.5 x 10 6 daltons.

has

an

The viral
approximate

The viral genome is

encapsidated in a 55 nm icosahedral shell and the virion lacks
a lipid containing envelope (Pfister and Fuchs, 1987).

The

genomes of several PVs have been sequenced

(Danos et al.,

1982, Schwarz et al., 1983, Seedorf et al.,

1985, Cole and

Danos, 1987) and it is clear that all PVs have a compact and

10
rather

similar

genomic

organization.

All

putative

open

reading frames {ORFs) as well as the long control region {LCR)
are on one DNA strand.
which

are

involved

The early (E) genes encode proteins
with

oncogenic

transcription, and replication.
structural

proteins

carrying

transformation,

DNA

The late {L) genes encode the
type-specific

and

species

specific antigenic d~terminants (Broker and Botchan, 1986).
The LCR of HPVs• is the noncoding 10% region of the viral
genome.

It contains transcriptional regulatory elements which

contribute to the

epitheliotrophic nature

of

elements include a tissue specific enhancer
1987,

Cripe et al.,

specific

octamer

1987)

binding

bound by a
protein

HPVs.

These

{Gius et al.,

cervical cell type

(Dent

et

al.,

1991),

glucocorticoid response elements (GREs) {Gloss et al., 1987),
interferon-responsive elements (Cohen et al., 1988), epidermal
growth factor response element (EGFRE) (Yasumoto et al., 1991)
as

well

as

transcription

factor

binding

sites

for

AP-1

(Garcia-Carranca et al., 1988), NFI {Gloss et al., 1989) and
keratinocyte specific transcription factors (Mack and Laimins,
1991).

DNase I footprinting analysis of the HPV LCRs detected

23 sites specifically bound by nuclear proteins {Gloss et al.,
1989).
a

It appears the epithelial specificity of HPV is due to

synergism

between

cellular

factors

found

at

certain

concentrations in epithelial cells rather than unique factors
present in these cells (Chong et al., 1991).
The majority of the HPV genome has been functionally

11
mapped.

ORF E2 encodes a pleiotropic protein which functions

as a transcriptional trans-activator (Phelps and Howley, 1987)
and a transcriptional repressor (Cripe et al., 1987).
protein binds as a

This

dimer to conserved palindromic motifs

repeated several times within the LCR (Gloss et al., 1987).
The

E2

protein

binds

to

SPl

sites

to

transactivate

transcription (Li et al., 1991) while a truncated E2 represses
1

transcription

(Cripe et al.,

1987).

ORF E4

is the most

abundant gene product in cutaneous HPV-1 infections (Doorbar
et

al.,

1986),

assigned.

although

no

specific

function

has

been

The functions of ORFs E5 and El are not yet known.

ORFs E6 and E7 encode two proteins which can:

1) immortalize

rodent and human cells (Matlashewski et al., 1987, Kanda et
al., 1988, Watanabe et al., 1988, Munger et al., 1989), 2)
transacti vate heterologous gene expression
1988,

Grossman

synthesis

et al.,

( Sato et al. ,

1989),
19 8 9)

3)

(Phelps et al. ,

stimulate

and 4)

play a

maintenence of viral DNA (Berg et al., 1986).
both nuclear proteins
Wettstein, 1986).
tissue,
1986) .

is a

(Grossman et al.,

1989,

cellular

DNA

role in the
E6 and E7 are
Smotkin and

E7, the major protein in cervical carcinoma

21 kd phosphoprotein

Ll and L2

(Smotkin and Wettstein,

encode the major and minor structural

proteins (Doorbar and Gallimore, 1987).
Pathogenesis of HPV.

Integration of HPV DNA into the

cellular genome was accepted as a prerequisite for progression
to cervical cancer since many carcinomas contained integrated
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viral DNA while benign HPV lesions contained episomal HPV DNA
(Durst et al., 1985).
forms

However, both episomal and integrated

of complete HPV-16 genomes are present

cervical

carcinomas

(Matsukura

et

al.,

in

invasive

1989) •

Thus,

integration may not be required for malignant progression but
it is the predominant form of HPV DNA in malignant lesions and
thought to play an i~portant role.
Viral integrati-0n usually results in the disruption of
the El and/or E2 ORFs and retention of E6, E7 ORFs and the LCR
(Durst et al., 1986, Matsukura et al., 1986, Pater and Pater,
1985) with subsequent deletion or rearrangement of cellular
sequences

(Wagatsuma

Wagatsuma et al.,

et

al.,

1990,

Choo

et

al.,

1990).

(1990) analyzed several cervical carcinoma

clones containing HPV-16 DNA flanked by cellular DNA sequences
to determine if there is specific integration.

No specific

target sequence was found either in the cellular genome or in
the

HPV-16

occurred

in

viral
the

genome,
El/E2

however,
ORF

integration

(Wagatsuma

et

frequently

al.,

1990).

Therefore, viral integration frequently disrupts the El/E2 ORF
but not at a specific site within the viral genome.
Al though propagation of HPV has not been possible in
vitro, the availability of recombinant viral DNAs has allowed
for transformation studies of high-risk HPVs specifically,
HPV-16 and HPV-18.

Early genes, E6 and E7, are intact and

expressed in nearly all malignant lesions (Pater and Pater,
1985, Matsukura et al., 1986).

Both E6 and E7 of high-risk
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HPVs

are

including
McDougall,

required

to

immortalize

keratinocytes
1988,

(Durst

primary

et

Woodworth et al.,

human

al.,

1987,

1989)

and

(Pirisi et al., 1987, Watanbe et al., 1989).

cells,

Kaur

and

fibroblasts
E7 alone can

transform established rodent cells (Kanda et al., 1988, Bedell
et al., 1989), cooperate with an activated ras to transform
primary cells (Matlashewski et al., 1987, Phelps et al., 1988)
and induce chromosomal abnormalities in murine keratinocytes
(Hashida and Yasumoto,

1991).

High-risk HPV infection of

primary cells does not usually induce tumors in nude mice,
however, long term cultivation may result in a malignant clone
(Hurlin et al., 1991).

The role of E6/E7 in the initiation

and maintenence of transformation was demonstrated by von
Knebel Doeberitz

et al.,

( 1988) .

Transfection of HPV-18

positive tumor cells (Hela), with hormone-dependent anti-sense
E6/E7 plasmid constucts resulted in reduced cell growth and
nontumorigenecity of HPV-containing cervical carcinoma cells.
A reduction of E6/E7 mRNA and E7 protein levels was detected
when compared to transfection with the sense orientation of
E6/E7 constructs (von Doeberitz et al., 1988).
ORFs

play

a

role

in

the

maintenence

of

Thus, E6/E7

the

malignant

phenotype.
Many subtle differences exist between the oncogenic and
nononcogenic
differs

in

HPV types.
these

two

The

types

physical
of

state

infections.

infections, the DNA remains episomal,

of
In

viral

DNA

low-risk

whereas in high-risk
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infections, the viral DNA is primarily integrated (Durst et
al.,

1985}.

The

E6/E7

ORFs

of

the

high-risk

HPVs

can

immortalize primary human cells while low risk HPVs cannot
(Sato et al.,

1989).

The generation of E6/E7 mRNAs also

The major transcript of mucosotrophic HPVs (both

differs.

high and low risk} is E7.

In high-risk HPVs, E7 is generated

from a colinear E6/~7 transcript by splicing out an intron
within the E6 ORF. Thus a full length E7 mRNA is synthesized
along with two short E6 mRNAs (E6*I and E6*II} (Smotkin et al.,
1989}.

In contrast, no splice site is present in low-risk

HPVs and thus only full
generated.

E6*I and E6*II were thought to encode type-specific

transforming peptides,
isolated.

length E6 and E7 transcripts are

however no truncated . proteins were

The function of the splice within E6 appears to

facilitate translation of E7 mRNA and reduce translation of
full length E6 rather than to generate active E6* proteins
(Sedman et al., 1991).
A common effect of infection with high risk HPVs

is

growth stimulation of cells (Hawley-Nelson et al., 1989, Sato
et al., 1989} leading to chromosomal abnormalities resulting
in cell aneuploidy (Durst et al., 1987, Smith et al., 1989}.
cytogenetic abnormalities were correlated with high-risk E7
gene functions but not with E6 (Hashida and Yasumoto, 1991).
Aneuploidy is seen primarily with high risk HPV infections,
while

low

risk

HPVs

do

not

aberrations (Fu et al., 1981}.

usually

cause

chromosomal

Thus, the ability of E7 to
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induce chromosomal abnormalities may be important with respect
to its immortalizing function.
Role

of

cellular

factors

in

progression.

Specific

cellular proteins also differ in their ability to bind HPV
viral oncoproteins.

The E7 oncoprotein of high-risk HPVs

binds to the retinoblastoma (RB) protein with a 10-fold higher
affinity than E7 pr9teins of low-risk HPVs
1989).
et

(Dyson et al.,

E6 binds to the tumor suppressor protein, p53 (Werness

al.,

1990)

and promotes degradation

protein (Scheffner et al., 1990).
are thought to play a

role

of

this

cellular

Both p53 and RB proteins

in cellular proliferation by

negatively regulating cell growth (Sturzbecher et al., 1990,
Decaprio et al.,

1989).

Mutations of these genes lead to

deregulation of the cell cycle resulting in hyperprolif eration
and chromosoma 1 instabi 1 i ty ( Hudson et a 1 • , 19 9 0 , Woodworth et
al.,

1990)

products

similar to the effect seen with the E6/E7 gene

of

high-risk

HPVs.

Therefore,

these

cellular

proteins may also be involved in the progression of high-risk
HPV infections.
Cell

specific

progression.

factors

may

also

play

a

role

in

HPV

Fusion of HPV positive cervical carcinoma cells

(Hela) with active E6/E7 expression and normal human cells
(fibroblasts)

produced

nonmalignant

hybrids

suggesting

cellular factors can override the effect of or downregulate
E6/E7 expression (Bosch et al., 1990) .

The suppressive effect

of cellular factors was also demonstrated when the HPV-18 LCR
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was placed upstream of the reporter gene chloramphenicol
acetyltransferase

(CAT).

Resulting

CAT

expression

extinguished in hybrids of cervical carcinoma cells
fused

with

nontumorigenic

immortalized

cycloheximide treatment (4 hrs)

was

(SiHa)

keratinocytes.

of hybrids resulted in the

reappearance of CAT expression suggesting suppression was due
to

a

labile

prote~n

(Rosl

nonmalignant keratinocytes.

et

al.,

1991)

present

in

Chromosomal aberrations may also

play a role in HPV pathogenesis.

It appears HPV-16 gene

expression in primary human fibroblasts is stimulated by a
deletion in one copy of chromosome 11 (Saxon et al., 1986).
Several studies have demonstrated that integration of
high-risk

HPV

DNA

into

the

cellular

genome

results

in

alterations of the c-myc protooncogene (Riou et al., 1987,
Durst et al., 1987, Crook et al., 1990).
c-myc gene

(Ocadiz

expression

(Crook et al.,

cervical carcinomas.

et al.,

1987)
1990)

Amplification of the

and enhanced c-myc RNA
was

observed

in

several

HPV-18 integration results in specific

activation of myc genes in genital tumors (Couturier et al.,
1991).

Taken together this suggests the c-myc oncogene may

also play a role in the pathogenesis of cervical cancer.
The long latency period, the relatively low number of
high-risk HPV infected individuals who develop progressive
cervical

cancer

as

well

as

the

presence

of

HPV-16

in

histologically normal tissue (MacNab et al., 1986, Tidy et
al.,

1988)

suggests that HPV alone is not sufficient for
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progression to invasive carcinoma. It has been hypothesized
that

herpes

simplex virus

2

(HSV-2)

cooperates with

the

oncogenic HPVs to produce the malignant phenotype (zur Hausen,
1983).
Growth characteristics of HSV-2.

HSV-2 is a large human

DNA tumor virus of the Herpesviridae family.

Classified as an

alphaherpesvirus, al9ng with herpes simplex virus 1 (HSV-1)
and varicella-zoster•virus (VZV), it can replicate efficiently
in a wide host range, spread rapidly in culture due to a short
life cycle,

and cause complete lysis of host cells.

In

addition to a lytic cycle, alphaherpesviruses cause latent
infections in sensory neurons

(Roizman,

1985) •

The HSV-2

virion consists of an enveloped icosahedral capsid enclosing
a DNA containing viral core.
viral genome is 150 kbp.

The approximate size of the

The structure of the HSV genome

includes two regions of unique sequences,
flanked by a set of inverted repeats

UL

and U8 ,

each

(reviewed in Roizman,

1985) .
Cytopathic effect

(CPE)

of replicating virus on host

cells is seen by an enlargement of cells and dissolution of
cell nuclei.

Viral CPE occurs in the parabasal cells of the

squamous epithelium.

A vesicle filled with cell debris,

inflammatory and multinucleated giant cells forms under the
cornified epithelium as cell lysis progesses.

The lesion can

spread into adjacent parabasal cells and rupture, releasing
viral antigens and evoking a subsequent host cell response
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(reviewed in Rawls, 1985).
HSV-2 is primarily spread by sexual contact and risk
factors associated with these infections are similar to those
of other sexually transmitted diseases (STD; Stavraky et al.,
1983).

In fact,

infections

many STD patients have concurrent HSV-2

(Knox et al.,

1982).

While most HSV-2 genital

infections are not ltfe threatening, an association between
HSV-2 and cervical carcinoma seems clear (Rawls et al., 1969,
Naib

et

al.,

1973,

McDougall

et

al.,

1980,

Nahmias

and

Norrild, 1980, DiLuca et al., 1989, Hildesheim et al., 1991).
Role of HSV-2 in transformation.

Duff and Rapp (1971,

1973) demonstrated that HSV-2 can transform mammalian cells.
Immortalization of hamster embryo fibroblasts was induced by
ultraviolet
1973) .

(UV) -inactivated

HSV-1

virus

(Duff

Immortalization by inactivated HSV-2,

and

Rapp,

either UV or

photodynamic, was also demonstrated in rodent (MacNab, 1974)
and

human

cells

(Takahashi

and

Yamanishi,

1974).

Thus,

inactivated HSV-2 virus will transform human cells, however,
virus is not recovered (Takahashi
and Gusdon, 1976).
run"

mechanism

to

&

Yamanishi, 1974, Kucera

Early experiments suggested a "hit and
describe

HSV

transformation

since

the

continued presence of HSV was not required for transformation
(Skinner, 1976, Galloway and McDougall, 1983).
Within

the

HSV

genome,

three

unique

morphological

transforming regions (mtr) have been identified.

Mtr I

is

contained in the HSV-1 genome and maps to a XbaI-F fragment
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(map unit 0.30 - 0.45) (Camacho and Spear, 1978).

The HSV-2

genome contains two regions capable of transforming cells, mtr
II and mtr III.

Mtr II is within the Bgl II-N fragment (map

unit 0.585 - 0.63) while mtr III is contained within the Bgl
II-C fragment (map unit 0.42 - 0.58) (Galloway and McDougall,
1981,

Jariwalla et al.,

1983).

The minimal transforming

region of mtr II is a, 730 bp fragment (Galloway et al., 1983) •
The HSV-2 mtr III contains a minimal transforming fragment of
486 bp (486 TF) which apparently does not encode an oncogenic
protein (Jones et al., 1986).

Rather, the viral DNA contains

multiple regions of alternating purines and pyrimidines, G+C
rich sequences, potential SPl transcription factor binding
sites, stem-loop structures and insertion-like elements (Jones
et

al.,

1986).

transcriptional

486
promoter

TF

also

element

functions
(Jones,

as
1989).

a

complex
It was

hypothesized that the multiple repetitive DNA sequence motifs
associated with recombination and gene activation in 486 TF
alter cellular gene expression

leading to transformation

(Jones, 1989).
Function of RR in HSV-2 mediated transformation.

The

role played by the HSV encoded ribonucleotide reductase (RR)
proteins in viral transformation has been examined since mRNAs
encoding this dual subunit protein are within the Bgl II-C and
Bgl II-N fragments (McLauchlan and Clements, 1982, swain and
Galloway, 1986).

HSV RR is composed of a large subunit, RRl,

and a small subunit, RR2 (Cohen et al., 1985, Frame et al.,
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1985, Bachetti et al., 1986).

The two transcripts have 3'-

coterminal ends with the 1.2 kb mRNA encoding RR2 contained
within Bgl II-N.

The 5. 0 kb mRNA encoding RRl has all but the

carboxy terminus within Bgl II-C (McLauchlan and Clements,
1982, swain and Galloway, 1986).

HSV-2 RRl was proposed as a

transformation specific protein (Huszar and Bacchetti, 1983),
however, 486 TF does,not encode the catalytic function of the
RRl.

This suggests-that RRl expression is not required to

induce transformation, at least in rodent cells (Jones et al.,
1986).

The amino terminus of RRl contains a 355 hydrophilic

amino acid

(aa) domain which does not share homology with

other herpesvirus RR enzymes (Swain and Galloway, 1986).

It

was recently demonstrated that a 290 aa polypeptide from this
domain was able to induce enhanced malignant transformation of
rodent cells (Ali et al., 1991) suggesting the entire RRl
protein is not necessary for transformation.

In summary, the

exact role RRl or RR2 plays in neoplastic transformation has
not been established.
Mutagenic effect of HSV-2.

The specific mechanisms of

transformation of HSV are not known.

However, certain aspects

of HSV resemble chemical mutagens which induce random cellular
alterations.

Since HSV-2 transformation does not appear to

require retention of viral DNA and a HSV encoded oncoprotein
has not been identified, it was hypothesized that HSV-2 could
induce stable, heritable changes in the cell which ultimately
leads

to

transformation

(Clarke

and

Clements,

1991).
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Herpesviruses efficiently induce chromosomal aberrations such
as breaks and rearrangments (Hampar and Ellison, 1961, Bejcek
and Conley, 1986) and act as a biological mutagens.
followed by cellular DNA repair

Damage is

( zur Hausen, 1983) .

HSV-2

infections of nonpermissive cells have been shown to increase
the mutation frequency of the cellular hypoxanthine-guanine
phosphoribosyl trans¾erase (HGPRT) gene by 2 to 10 fold (Pilon
et al., 1985).

The ~utation rate of HGPRT was 5 to 10 fold

higher than background when human cells were infected with
inactivated HSV-1.

The effect was comprable to the chemical

carcinogen 4-nitroquinoline-1-oxide (4-NQO)
zur

Hausen,

1982).

Neither

viral

(Schlehofer and

replication

nor

gene

expression is required for the mutagenic effect of HSV (Clarke
and Clements, 1991).

Thus, mutagenesis may be an important

mechanism used by HSV in carcinogenesis.
Another mechanism by which HSV is suggested to transform
cells

is

gene

amplification.

Studies

have

demonstrated

inactivated HSV can amplify genes with similar efficiencies as
chemical carcinogens (Lavi, 1981, Schlehofer et al., 1983).
HSV-2

DNA secondary structure has been

transformation

process.

Both

the

implicated in the

minimal

transforming

fragments of Bgl II-N (730 bp) (Galloway et al., 1983) and Bgl
II-C (486 TF) (Jones et al., 1986) have unique DNA sequences.
Both are able to form stem-loop structures which may promote
DNA

insertions

Additionally,

and

transpositions

(Jones

et

al.,

1986).

486 TF contains sequences able to form Z-DNA
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which

is

implicated

chromosomal

in

homologous

destabilization

Recombination between HSV-2

(Nickol

recombination
et

al.,

and

1982).

and cellular DNA can lead to

deregulation of cellular genes (MacNab et al., 1985, Leavitt
et al. ,

1985) •

Viral recombination also results

in the

excision of extrachromosomal plasmids containing viral DNA
sequences fused to a~tered cellular sequences (Jariwalla et
al.,

1986).

Therefore,

HSV-2

DNA

important factor in transformation.
HSV-2

to

induce cervical

structure

may

be

an

Recently, the ability of

neoplasia was

demonstrated when

inactivated whole virus was applied to the mouse cervix and
analyzed

for

the

presence

of

lesions (Anthony et al., 1989).

premalignant

and

malignant

Lesions, similar to those

seen in women with cervical carcinoma, were detected in 61% of
the mice of which 21% were invasive carcinomas.

No cancers

were detected in control animals treated with uninfected HEp-2
cellular DNA or calf thymus DNA (Anthony et al. , 1989) .

Thus,

in an animal model HSV-2 can induce cervical carcinoma.
Epidemiology of HPV /HSV-2 in cervical carcinoma.

studies

assessing the possible correlation between HSV-2 DNA and highrisk HPVs in the pathology of cervical carcinomas have looked
for the simultaneous presence of both viral DNAs in genital
tumor tissues (DiLuca et al., 1987, 1989, Hildesheim et al.,
1991).

Thirty percent of genital tumor tissue had homology to

HSV-2 mtr II and mtr III fragments (DiLuca et al 1989) while
6/8 tumors (DiLuca et al., 1989) and 8/8 tumors (DiLuca et
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al., 1987) showing homology to HSV-2 DNA sequences were also
positive for HPV-16/18 DNA.

Seroepidemiological studies have

shown that women with cervical cancer had higher levels of
HSV-2 specific antibodies than controls (Kaufman and Adam,
1986).

Hildesheim

interaction

et

between

al.,

HSV-2

(1991)

and

found

HPV-16/18.

a

significant

In

HPV

16/18

positive women, HSV-~ seropositive women had a 60% increased
risk of cervical cancer compared to seronegative women.
results

suggest

oncogenic viruses.

a

possible

synergism

between

These

these

two

A transformed keratinocyte cell line with

HSV-2 mtr II DNA and HPV-16 DNA can produce tumors in nude
mice.

In contrast, HPV-16 immortalized parental cells do not

(DiPaolo et al., 1990) implying Bgl II-N plays a role in the
progression to carcinoma.

Thus, several lines of evidence,

molecular as well as epidemiological, implicate HSV-2 and HPV16/18 as cofactors in the development of cervical carcinoma.
The frequent incidence of high-risk HPV nucleic acids in
cervical carcinoma biopsies has suggested these viruses play
a role in the induction of genital cancer.

However,

the

presence of high-risk HPV containing tissue which is histologically normal (MacNab et al., 1986) suggest other factors
play a role in progression.
a biological mutagen,

HSV-2, with its ability to act as

is a viable candidate to mediate the

progression of high-risk HPV infection to genital cancer.

METHODS AND MATERIALS

Cells.

Human fibroblast cells, R-30, N-16, and C-1, were

obtained from Dr. Tom Hassell.

These cells were split in 1:3

ratios weekly and ma~ntained in Earles modified Eagles medium
(Sigma)

supplemented with 10% fetal bovine serum

(Sigma),

penicillin (10 U/ml), and streptomycin (100 ug/ml).

Primary

human

keratinocytes,

and

FE-A,

immortalized

cell

lines)

McDougall.

Keratinocytes

FEP-L

(HPV-18,

were

obtained

from

were

maintained

HPV-16

Dr.

in

James

serum-free

keratinocyte medium (Gibco) supplemented with epidermal growth
factor

(5 ng/ml)

and bovine pituitary extract

(50 ug/ml),

penicillin (10 U/ml) and streptomycin (100 ug/ml).

Cells were

split 1:4 weekly.
Plasmids.

Plasmid HZIP-16 was obtained from Dr.

G.

Matlashewski and contains 6.6 kb of the HPV-16 genome flanked
by the Moloney murine leukemia virus long terminal repeats
(Matlashewski et al., 1987).
was

deleted

undisturbed.

for

cloning

A 1.3 kb fragment of the Ll ORF

purposes.

All

other

ORFs

are

Plasmid pEJ6.6 containing the Ha-ras oncogene

was obtained from ATCC

(#41028,

Rockville,

pHPV18 containing the entire HPV-18 genome
obtained from Dr. James McDougall.
24

MD).

Plasmid

(7857

bp)

was

Two c-myc plasmids were
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used in the analysis.

Plasmid p5-UTR containing a 1.6 kb Sac

I fragment of the 5'-untranslated region of the c-myc gene,
was obtained from ATCC (#39286, Rockville, MD)

and plasmid

pEX2, containing a 420 bp Pst I fragment of exon 2 of c-myc
DNA,

was

obtained

from Dr.

Len Erickson.

Plasmid php53

containing a 2.1 kb Bam HI human p53 cDNA insert was obtained
from Dr. Moshe Oren.,

All of the HSV-2 plasmids contained

various sequences derived from HSV-2 mtr III and contained the
ampicillin resistance gene (Jones et al., 1986).
Calcium phosphate

transfection

of

fibroblasts.

Low

passage R-30 cells or N-16 cells were transfected with 25 ug
DNA using calcium phosphate precipitation (Graham and Van der
Eb, 1973).

A 25% DMSO shock was used to facilitate uptake of

DNA following calcium phosphate precipitation.

Seventy two

hours after transfection, the antibiotic geneticin (Sigma) was
added

to

the

cultures

containing plasmids.

(400

ug/ml)

to

select

for

cells

All cultures were cotransfected with

pSV2neo (5 ug/60mm dish).

Geneticin selection was carried out

for 2-3 weeks post transfection or until all the cells in the
control dish were dead.

When densely growing colonies became

macroscopic

the

in

size,

cells

were

trypsinized

and

subcultured as described above in the absence of geneticin.
Polybrene transf ection of keratinocytes.

Due to the

toxicity of calcium phosphate on keratinocytes, the polybrene
transfection method (Rhim et al., 1986) was used for these
cells.

Polybrene,

hexadimethrine

bromide

(Sigma),

is

a
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cationic compound which disrupts cell membranes and allows for
DNA passage into cells.

Either normal human keratinocytes

(NHK) or immortalized HPV cell lines, FE-A containing HPV-18
or

FEP-L

containing HPV-16,

were

transfected

with

10

ug

plasmid DNA using 10 ug polybrene (1 mg/ml) in 1 ml serum-free
medium ( SFM) •

Cultures were incubated at 37°

c and rocked

A 30% DMSO shock (4 minutes) was performed after
'
6 hours to facilita.te uptake of DNA.
All cultures were

every hour.

cotransfected with pSV2neo (2 ug/60 mm dish).

Forty eight to

seventy two hours after transfection, geneticin was added to
cultures

(50 ug/ml for FE-A cells and 500 ug/ml for FEP-L

cells) to select for cells with plasmids.

Genetic in selection

was carried out for 3-5 weeks post transfection or until the
control cells were dead.

When densely growing geneticin

resistant cells became macroscopic, cells were trypsinized and
cultured in the absence of geneticin.
Isolation of high molecular weight DNA.

This procedure

has been previously described by Maniatis et al.,
Tissue culture cells were washed and trypsinized.
centrifuged for 10 minutes.

(1986).

Cells were

The pellet was washed in TKMC

solution ( 10 mM Tris pH 7. 5, 10 mM KCl, 1 mM MgC1 2 , 5 mM CaC12 )
and resuspended in 500 ul TKMC solution and 25 ul 10% Triton
X-100 and incubated on ice for 5 minutes.

The cell suspension

was centrifuged and the pellet resuspended in 250 ul TNE
solution (50 mM Tris pH 7.5, 100 mM NaCl, 10 mM EDTA), 2.5 ul
10% SOS and 100 ug RNase A.

Samples were incubated at 37° C
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for 1.5 hours and 7.5 ul Proteinase K (20 mg/ml) was added and
samples were incubated overnight at 37°

c.

The samples are

extracted two times with phenol: chloroform: isoamyl alcohol
(50:49:1).

Two volumes of 95% ethanol was added and samples

were shaken for an additional 30 minutes followed by a
minute spin.

The ethanol precipitation was repeated.

5

The

pellet (after a secon~ ethanol wash) was dried and resuspended
in TE buffer ( 10 mM Tris-Hcl, pH 7. 4, 1 mM EDTA) •

The genomic

ONAs were digested with the indicated restriction enzyme (10
U/ug).

The

quantities

of

DNA

was

estimated

by

scale

isolation

and

electrophoresing on a 1% minigel.
Plasmid

DNA

isolation.

Large

minipreparations of plasmid DNA were performed by the alkaline
lysis method described by Maniatis et al., (1989).

For large

scale isolation, the bacteria with the respective plasmid were
shaken in overnight 5 mls of Luria broth (LB) with 50 ug/ml
ampicillin
inoculate

(Sigma).
a

ampicillin.

one

This

liter

LB

5

ml

preculture

culture

was

containing

used
50

to

ug/ml

The culture was incubated at 37° C with vigorous

shaking until it reached an O.D. 595 of 0.6-0.7.

Fifty ug/ml

chloramphenicol (Sigma) was subsequently added to cultures and
incubation with shaking was continued overnight.

Bacteria

were harvested by centrifugation at 8000 rpm for 10 minutes at
4° c in a Beckman JA-10 rotor.

The pellet was resuspended in

9 ml of solution I containing 50 mM glucose, 25 mM Tris-HCl,
pH

8. o,

10

mM

EDTA,

pH

8. o.

Bacterial

membranes

were
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disrupted by addition of 1 ml fresh lysozyme solution (5 mg
1ysozyme in solution I) and incubated for 5 minutes at room
Cells were

temperature.

lysed

by

addition

of

20

ml

of

solution II containing 0.2 N NaOH, 1% sos (w/v) and kept on
ice for 10 minutes.

Twenty ml of an ice-cold solution of 5 M

potassium acetate (pH 4.8) was added and tubes were shaken
vigorously and subsequently
incubated on ice for 10 minutes.
,
The lysates were tran~ferred to two 50 ml Oak Ridge tubes and
centrifuged at 20,000 rpm at 4° C in a Beckman JA-20 rotor for
20 minutes.

The supernatant was transferred to 2 new Oak

Ridge tubes and 0.6 volume of isopropanol added.

DNA was

precipitated for 15 minutes at room temperature and tubes were
centrifuged for
rotor.
For

30 minutes at 20° C in the Beckman JA-20

The pellets were resuspended in 2.4 ml TE buffer.
purification

of

supercoiled

plasmid

DNA,

cesium

chloride (CsCl)-ethidium bromide equilibrium centrifugation
was performed.

For each ml of DNA solution, 1 g CsCl and

ml ethidium bromide (10 mg/ml) was added.

o.a

The samples were

centrifuged in a Beckman VTi 70 rotor at 50,000 rpm for 20
hours at 20°

c.

Closed circular plasmid DNA was removed by

side puncture and the CsCl gradient was repeated.
bromide

was

removed

by

repeated

alcohol saturated with CsCl.
adding 8 ml TE buffer

extraction

with

Ethidium
isoamyl

Plasmid DNA was precipitated by

(to reduce CsCl concentration), two

volumes of ethanol and incubated at -20° c overnight.

DNA was

pelleted by centrifugation at 12,000 rpm for 30 minutes at 4°
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c and resuspended in TE buffer.
For minipreparations of plasmid DNA, a 1.5 ml LB culture
with 50 ug/ml ampicillin and the specific bacterial colony was
incubated at 37° c with vigorous shaking overnight.

Samples

were centrifuged

100 ul

for

1 minute

and

resuspended

in

solution containing 50 mM glucose, 10 mM EDTA pH 8.0, 25 mM
Tris-Hcl pH 8.0, 4 mg/ml lysozyme and incubated for 5 minutes
at room temperature.·

To the cell suspensions, 200 ul of a

fresh solution of 0.2 N NaOH,

1% SOS was added followed by

another 5 minute incubation at room temperature.

One hundred

fifty ul of an ice-cold solution of 5 M potassium acetate (pH
4.8)

was added,

samples placed on ice for

subsequently

centrifuged

supernatant

was

extracted

phenol:chloroform:isoamyl
layer was removed.

for

5 minutes,

5

minutes

at

with

an

equal

alcohol

(25:24:1).

4°

c.

The

volume
The

and

of

aqueous

DNA was precipated by the addition of 2

volumes of ethanol for 10 minutes at room temperature and
pelleted by centrifugation.

Pellets were washed with 70%

ethanol, dried in a vacuum, and resuspended in TE buffer.
Electrophoresis.

Two types of gel electrophoresis were

performed.
a)

Agarose

gel

electrophoresis.

Undigested

and

digested genomic DNA samples were analyzed by electrophoresis
on horizontal 1% agarose gels.

Gels were prepared in a buffer

(lX TBE) containing 89 mM Tris-borate, 2 mM disodium EDTA, pH
8.0 (TBE) and 0.5 ug/ml ethidium bromide (w/v).

Samples were
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suspended in TE buffer and gel loading dye (250 mM EDTA, 1%

sos,

0.1%

bromphenol

blue

(w/v),

50%

glycerol).

Electrophoresis was carried out at 5 V/cm for 3 hours and lX
TBE used as the running buffer.
b)

Polyacrylamide gel electrophoresis {PAGE).

Small

DNA fragments digested with restriction endonucleases were
separated

on

6%,

nondenaturing

polyacryamide

gels.

Electrophoresis was carried out for 16 hours at 5 mA in lX TBE
buffer.

Gels were stained with 5 ug/ml ethidium bromide and

subsequently visualized with an ultraviolet transilluminator
(305 nm).
Isolation of DNA fragments from agarose or PAGE gels.
Agarose or polyacrylamide gels stained with e~hidium bromide
were

visualized

with

an

ultraviolet

transilluminator.

Specific DNA bands were excised from the gel with a razor
blade and placed into dialysis bags containing 500 ul TE
buffer.

The DNA was electroeluted from the gel slice in 0.5X

TBE running buffer
purified

by

(Maniatis et al.,

1986).

phenol:chloroform:isoamyl

The DNA was

alcohol

{25:24:1)

extraction, an ether extraction, and concentrated by ethanol
precipitation.
Labelling of DNA probes.

Probes labelled with

were prepared by random priming from a
[alpha-32PJ-dCTP.
unincorporated
chromatography.
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P-dCMP

kit by IBI using

The labelled probes were separated from
nucleotides

by

Sephadex

G-50

(Pharmacia)

The probes were eluted with NETS solution
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containing 0.1% SOS, 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM
disodium

EDTA,

unincorporated
counter.
10

X

pH

8. o.

Separation

nucleotides

was

monitored

probe

with

a

from
Geiger

Specific activity of the probe was approximately 5-

107 cpm/ug DNA.
southern blot hybridization.

gels,

of

DNA was

Prior to blotting agarose

parti~lly depurinated in O. 25 N HCl for 15

minutes, denatured ift 0.5 M NaOH-0.9 M NaCl for 1 hour (two 30
minute incubations) and neutralized in 0.5 M Tris-HCl- 0.9 M
NaCl (pH 7.6) for 1 hour (two 30 minute incubations).

The

gels were subsequently transferred to nitrocellulose (Micron
Separations, Inc., Westboro, MA) (Maniatis, 1989) with 20X SSC
( lX SSC is 150 mM NaCl,

15 mM Na-citrate,

pH 7. 0) .

membranes were prehybridized in 50% formamide,

The

5X SSC, 0.1%

sos (w/v), 0.05M disodium phosphate, pH 6.8, 2X Denhardt's (lX
Denhardt's is 0.02% ficoll,

0.02% polyvinylpyrrolidone and

0.02% bovine serum albumin) and 50 ug/ml sheared salmon sperm
DNA

for

2

hours

at

42°

c.

The

hybridization

solution

contained the same components as the prehybridization solution
in addition to the heat-denatured probe.
hybridized at 42° c overnight.

Membranes were

The filters were washed 3

times in 2X SSC, 0.2% SOS for 20 minutes each and subsequently
washed 3 times in

o. 2X SSC, O. 5% SOS for 2 O minutes each. All

filters were air dried and placed in X-ray cassettes with
Cronex Lightning Plus intensifying screens (DuPont) and Kodak
X-OMAT AR film at -80° C.
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Isolation of total cellular RNA.

Total cellular RNA was

extracted from cells by the method of Chomczynski and Sacchi
(1987).

Cells

(approximately 1 x

10 6 )

were washed with

phosphate-buffered saline (PBS) and lysed with 1.8 ml of a
solution containing 4 M guanidine thiocyante, 25 mM sodium
citrate, pH 7.0, 0.5% sodium lauryl sarcosinate, and 0.1 M 2mercaptoethanol.

Ly~ates were transferred to new tubes to

which 180 ul of 2 M sodium acetate, pH 4.0, 1.8 ml of watersaturated phenol and 360 ul chloroform:isoamyl alcohol (49:1)
was added to each sample.

Samples were incubated on ice for

15 minutes followed by a 30 minute centrifugation at 4000 rpm
at 4°

c.

The aqueous phase was transferred to new tubes and

RNA was precipitated overnight at -20° c with an equal volume
of isopropanol.
rpm at 4° C.

RNA was pelleted by a 30 minute spin at 4000

The RNA pellet was resuspended in 200 ul lysis

solution and reprecipitated in a microfuge tube.

The pellet

was resuspended in TE and stored at -70°C.
Cloning HPV-16 DNA fragments into recombinant plasmids.
Plasmid HZIP-16 was digested to completion with Bam HI, to
remove the HPV-16 DNA insert, followed by digestion with Pst
I

to obtain vector-free HPV-16 fragments.

Plasmid pT7T3

containing dual opposable RNA polymerase promoters, T7 and T3,
was also digested with Bam HI and Pst I or with Pst I alone.
To prevent self-ligation of the vector,

the 5' -phosphate

groups were removed with bacterial alkaline phosphatase (IBI).
All DNAs were ethanol precipitated and resuspended in TE
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buffer.

The ligation reaction mixture contained vector and

insert DNA at a concentration ratio of 1:1 and 1 unit of T4
ligase.

Reactions were incubated overnight at 15°

c.

A 5 ml culture of Escherichia coli strain HBl0l was grown
overnight and used to inoculate 100 ml of LB.
grown until O.D. 595 of 0.6-0.7.

The culture was

Cells were pelleted at 2000

rpm for 10 minutes (JpuAn CR412), resuspended in 20 ml of 100
mM

CaC121

centrifuged again

for

10 minutes

at

2000

rpm,

resuspended in 10 ml 100 mM CaC12 and incubated on ice for 1
hour.

Bacteria was added in either a 200:1 or 20:1 ratio

(v/v) to the ligation mixture.

Samples were incubated on ice

for 40 minutes followed by a 2 minute incubation at 45°

c.

Subsequently, 1 ml of LB and 3 ml of top agar ,(0.137 M NaCl,
10%

casein

o. 8%

hydrolysate,

transformation

mixtures

containing

50

ug/ml

ampicillin

were

endonuclease

were

agar)

poured

ampicillin.

analyzed

analysis

for

after

was

onto

LB

Colonies

insert

DNA

mini-preps

by

were

added
agar

and

plates

resistant

to

restriction
performed

as

described above.
Generation of RNA probes.

RNA probes were generated by

in vitro transcription kits from Ambion.

Target DNA was

cloned into multipurpose cloning vectors with dual opposable
RNA polymerase promoters,

pSP6T7,

pT7T3.

To detect mRNA,

complementary RNA or antisense RNA was synthesized.

Vector

DNA was linearized with a restriction endonuclease on the
amino

terminus

of

the

encoded

gene

product

to

generate
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antisense

transcripts.

Template

phenol:chloroform:isoamyl alcohol
ether

extraction

to

remove

resuspended in TE buffer.

any

DNA

was

(25:24:1)
RNAses,

extracted

with

followed by an

precipitated

and

For the in vitro transcription, the

reaction contained 1 ug of linearized template DNA, 1 ul of 10

mM stock concentrations of ATP, GTP, and CTP, 2 ul of l0X
transcription buffer, (supplied by Ambion),

1 ul of 200 mM

dithriotol (DTT), 1 ul placental ribonuclease inhibitor, 5 ul
of [ alpha-32P]-UTP ( 400-S00Ci/mmol) , and 1 ul of the specific
RNA

polymerase

transcripts.

needed

for

generation

of

the

antisense

The reaction was incubated at room temperature

for 30 minutes and the reaction terminated by the addition of
1 ul of DNase I for 15 minutes at 37°

c.

Subsequently, 20 ul

gel loading buffer (80% formamide, 0.1% xylene cyanol (w/v),
0.1% bromphenol blue (w/v), 2 mM disodium EDTA) was added and
samples denatured for 5 minutes at 85°

c, and electrophored on

8 M urea/5% acrylamide gels at 150 V for 30 minutes.

The gel

was autoradiographed, the full length RNA transcript excised,
the gel slice placed in 350 ul elution buffer (0.5 M ammonium
acetate, lmM disodium EDTA, 0.1% SOS), and eluted overnight at
37°

c.

The amount of radioactivity present in the eluted

probe was determined by liquid scintillation counting.
Northern blot hybridization.

Total cellular RNA (10 ug)

was electrophoresed through a 1% agarose gel containing 0.66
M

formaldehyde

and

lX

MOPS

buffer

(200

mM

3-[N-

morpholinopropane-sulfonic acid], 5 mM sodium acetate, pH 7. 0,
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1 mM disodium EDTA).

Prior to electrophoresis, 10 ug RNA was

precipitated and redissolved in sample buffer containing 0.75
ml deionized formamide, o .15ml l0X MOPS, 0. 24 ml formaldehyde,

o .1 ml RNase free water, 0 .1 ml glycerol and o. 08 ml 10%
bromphenol blue {w/v).

RNA was transferred to nylon filters

(Hybond N+, Amersham) by blotting overnight in 20X SSPE {lX
~

SSPE contains 0.18

NaCl,

disodium EDTA, pH 7. 7).
{l x 107 cpm/ug DNA)

0.01 M sodium phosphate,

1 mM

Probes labelled with (alpha-32P]-dCTP
were prepared by random priming and

hybridized to filters in a solution containing 5X SSPE, 5X
Oenhardt's solution,

0.5% SOS,

sheared salmon sperm DNA.
42° C for 16 hours.

50% formamide and 50 ug/ml

Hybridization was carried out at

The filters were washed with 2X SSPE and

0.1% SOS two times for 10 minutes at room temperature followed
by lX SSPE and 0.1%

sos

c.

for 15 minutes at 65°

Filters were

air dried and autoradiographed.
protection

Ribonuclease

analysis.

Ribonuclease

protection analysis {RPA) was performed using the RPA kit by
Ambion.
was

An in vitro generated RNA probe {7 x 104 cpm

mixed with

10

ug total

cellular RNA.
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P-UTP)

Samples were

precipitated with 0.5 M ammonium acetate and 2.5 volumes of
ethanol

and

resuspended

in

a

hybridization

buffer

{80%

formamide, 40 mM PIPES pH 6.4, 400 mM sodium acetate, pH 6.4,
1 mM EOTA), denatured for 4 minutes at 85°C and hybridized
overnight

at

45°

c.

Unprotected

single

stranded RNA

on

hybrids was digested with a solution containing RNase A/RNase
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Tl for 30 minutes at 37° C.

Equal volumes of 20% SOS and

proteinase K were added and samples incubated for 15 minutes
at

c.

37°

Subsequently,

samples

were

extracted

phenol:chloroform:isoamyl alcohol (25:24:1).

with

The RNAs were

precipitated with 2. 5 volumes of ethanol and run on a 8 M
urea/5% acrylamide denaturing gel to separate the RNA species.
The gel was dried and subjected to autoradiography.
Anchorage indep~ndent growth analysis.
cloning

efficiency

of

transformed

To determine to

cells

anchorage independent analysis was done.

in

soft

agar,

Base plates were

made with equal volumes of 1. 2% molten agar and 2X growth
medium

containing

glutamine,
serum,

Eagle's

sodium bicarbonate

penicillin

(10 U/ml)

modified
(pH
and

resulting in a 0.6% agar mixture.
cells)

Essential

7. 2),

20%. fetal

streptomycin

(100

medium,
bovine
ug/ml)

Cells suspensions (1 X 105

diluted in lX growth medium were mixed with equal

volumes of 0.6% agar and immediately poured onto base plates.
Plates

were

allowed

transferred to a 37°

to

c

solidify at

C02 incubator.

room temperature

and

Colonies were counted

after 2-4 weeks.
Polymerase chain reaction (PCR} analysis.

High molecular

weight DNA was prepared from various cell lines as previously
described and digested with either Eco RI or Pst I overnight
at 37°

c.

Oligonucleotide primers (Genosys Biotechnologies)

21 bases in length, were chosen to amplify a target sequence
of 366 base pairs located within the HSV-2 mtr III 486 TF
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sequence.

The primers were synthesized according to the

published sequence of 486 TF (Jones et al., 1986}.
contained nucleotides 917

to 937 of the plus strand

TCACGGAGGACGACTTTGGGC-3')
nucleotides

1262

to

Primer 917

and

1282

primer

of

the

1262

minus

The probe used

GCGTGTTCGGGGTGCTGTGGA-3').

(5'-

contained
strand

to

(5'-

detect

amplified sequence w~s the 486 TF sequence (486 bp).

the

PCR was

performed in 100 ul• volumes in standard commercial buffer
(Promega) containing 1.5 mM MgC1 2 •

Cycling parameters for PCR

were: 1 minute at 94° C for denaturation, 1 minute of primer
annealing at 60°

c,

and 2 minutes at 72°

total of 40 cycles was run.
used.

c

for extension.

A

For PCR, 1 ug of template DNA was

Amplification products were analyzed on 2% Nu-Sieve 3: 1

agarose (FMC Bioproducts) gels containing lX TBE buffer and
0. 5

ug/ml

ethidium bromide.

Subsequently,

Southern

analysis of the gels was done using random primed
486 TF probes.
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blot

P-labelled

Prehybridization was carried out for one hour

at 61° C in 5X SSPE, 5X Denhardt's and 1%

sos.

Blots were

hybridized in the same solution to which the denatured probe
was added.

Membranes were washed in lX SSPE and 1%

times at room temperature and once at 65°

c.

sos

three

Filters were air

dried and subjected to autoradiography.
Precautions were taken to avoid DNA carryover.
of pre-target and post-target DNA was done

Isolation

in physically

different areas, disposable labware and positive displacement
pipettes were used for all DNA manipulations, and protective
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covering for clothing, hair and face was used.

A positive

control for all PCR analysis was a plasmid, p486, containing
the 486 TF insert (Jones et al., 1989).

Negative controls

were

keratinocytes

DNA

from

normal

cells

(either

or

fibroblasts) containing no virus (neither HPV-16, -18 or HSV2)

and

the

"no

template"

reactions

which

components of the PCR, reaction except template.

contain

all

"No template"

lanes provided a control on the performance of the PCR.
Tumorigenicity assay in nude mice.

To determine the

oncogenic potential of transformed cell lines, 5 x 106 cells
were injected subcutaneously into nu/nu mice (Harlan Sprague
Dawley).
lesions.
sacrificed
dislodged

Mice were observed weekly for

the presence of

Seven to eight weeks post-injection_, animals were
and

lesions

from

tissue

removed.
with

Tumorigenic

Dispase

(Boeringer

cells

were

Mannheim)

overnight and subsequently plated in serum-free keratinocyte
medium (Gibco).

RESULTS

To demonstrate that human papillomavirus types 16/18 and
human herpes virus-2 can act as cofactors in the development
of cervical cancer, the experimental approach taken was to
'

establish human cells containing both viral DNAs.

The first

half of the Results section will examine and characterize
primary fibroblast cell lines generated from two human cell
strains.
cell

The second half of the Result section will examine

lines

generated

from

primary

genital

keratinocytes

transfected with transforming domains of both viruses.
Selection of primary human fibroblasts.

Two primary

human cell types derived from gingival tissue were utilized.
Gingival fibroblasts were obtained from 1) a normal individual
(N-16) and 2) from an epileptic patient treated with phenytoin
(R-30), an anti-seizure drug (Delgado-Escueta et al., 1983).
A common side effect of phenytoin is the induction of gingival
overgrowth.

Approximately 50% of patients taking this drug

have gingival hyperplasia and overgrowth can lead to complete
obstruction of teeth {Hassell et al., 1983).

Pseudolymphoma

syndrome and Hodgkin's disease are associated with prolonged
use of phenytoin (reviewed in Wolf et al., 1985).

Cells were

scraped from gingival tissue of normal and epileptic patients
39
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and primary cultures developed from the respective tissue.
This aspect of the investigation was designed to determine if
R-30 cells
primary

(hyperplastic

cells}

in vivo)

differ

with

and N-16

respect

cells

to

(normal

morphological

transformation by HSV-2 and/or HPV-16.
Transfection analysis of fibroblast cell lines.

To test

for morphological tr~nsformation of R-30 and N-16 cells, a
plasmid

containing ·the

early

genes

of

HPV-16,

HZIP-16

(Matlashewski et al., 1987) (Figure 1), was transfected either
alone

or

in

combination

with

plasmids

containing

HSV-2

sequences derived from morphological transforming region III,
mtr III (Jones et al., 1986}, into the respective cell lines.
In addition, a plasmid containing an activat~d H-ras gene,
pEJ6.6, was cotransfected with HZIP-16 to serve as a positive
control for cooperation with HPV-16.
(1987}

demonstrated

HPV-16

and

H-ras

Matlashewski et al.,
could

cooperate

to

transform primary cells. Table 1 shows the results from the
transfection experiments using N-16 and R-30 parental cells.
Phenytoin-treated

cells

(R-30)

were

more

susceptible

to

immortalization by HZIP-16 alone compared to fibroblasts from
a normal individual (N-16).

These differences were not merely

due to higher levels of plasmid DNA uptake in R-30 cells since
both cell types contained similar levels of DNA at 48 hours
post transfection (data not shown).

When H-ras, an activated

cellular oncogene, was transfected into R-30 cells or N-16
cells alone, densely growing genetic in resistant colonies were

41

Figure 1.
(I)
oRFs.

Schematic map of HPV-16 and HZIP-16.

Restriction enzyme map of HPV-16 genome and location of
The prototype HPV-16 genome is depicted.

To construct

HZIP-16, the region between Barn HI and Eco RI was deleted by
Matlashewski et al (1987).

HZIP-16 contains Molo"ney murine

leukemia virus LTRs, a neomycin resistance gene, origins of
replication of SV40 and pBR322 vector sequences.
long control region of HPV-16.

LCR is the

Restriction enzyme sites are

K (Kpn I), H (Hine II), S (Stu I), E (Eco RI) and B (Barn HI).
This plasmid was used as source of HPV-16 DNA to, generate all
fibroblast cell lines.
(II)
TF.

Restriction map of HSV-2 mtr III region containing 486
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Table 1.

Transfection analysis of R-30 and N-16 cells.

N-16

R-30

HZIP-16/H-ras
HZIP-16/486 TF
HZIP-16/BglII-C
HZIP-16
H-ras
HSV-2 486 TF
HSV-2 BglII-C
pSV2neo

Exp 1

Exp 2

Exp 3

Exp 1

Exp 2

Exp 3

4
5
6
5
1
0
0
0

7
4
2
7
0
0
0
0

5
6
7
4
0
0
0
0

3
4
0
0
0
0
0
0

6
3

7
5
0
0
0
0
0
0

3

1
0
0
0
0

R-30 or N-16 cells (5 x 105 cells/60 nun dish) were transfected with 25 ug of
plasmid DNA using the calcium phosphate precipitation procedure (Graham and
Van der Eb, 1973) followed by geneticin selection (400 ug/ml).
Values
indicate the number of geneticin resistant colonies per 60 nun dish.
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not observed. The geneticin resistant colony observed in H-ras
transfected

R-30

cells

senesced

transferred to a new dish.

when

trypsinized

and

Furthermore, cells transfected

with pSV2neo alone did not yield densely growing geneticin
resistant colonies. Since an activated H-ras oncogene will
transform immortalized human and rodent cells but usually not
primary cells (Newbold and Overell, 1983, Sager et al., 1983),
it appears R-30 and· N-16 cells are not immortalized. When
geneticin resistant colonies from N-16 cells were trypsinized
and passaged

(three independent experiments and resistant

colonies from 12 plates transfected with HZIP-16 alone, HZIP16/H-ras or HZIP-16/486 TF, HZIP-16/Bgl II-C, HZIP-16/Bam HIE),

stable cell lines were not obtained regardless of the

transforming

sequences

In contrast, geneticin resistant colonies obtained
transfected

with

only

HZIP-16

four

cells.

passages.

cells

after

these

these

R-30

senesced

into

Typically

from

cells

transfected

alone

or

or

five

in

combination with H-ras or HSV-2 DNA sequences underwent at
least 75-80 population doublings (PD) after trypsinization of
the original colony in the absence of geneticin.

Table 2

contains a

and the

summary of the

fibroblast

primary cells used in the analysis.

cell

lines

In summary, these studies

demonstrated that HPV-16 DNA immortalized R-30 cells more
efficiently

than N-16

cells

and neither

cell

strain was

transformed by H-ras alone.
Retention of viral DNA in transformed cell lines.

The
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Table 2.

Fibroblast cell lines.

PRIMARY or PRIMARY-LIKE CELLS:
N-16 - primary gingival fibroblasts
R-30 - hyperplastic gingival fibroblasts
(phenytoin treated)
C-1 - cyclosporin treated gingival

fibroblasts
CELL LINES:

140

-

141

-

139

145
181
227
228
268

-

HZIP-16 I H-ras
HZIP-16 I HSV-2 486 TF
HZIP-16 I HSV-2 Bgl II-C·
HZIP-16
HZIP-16
HZIP-16 I {H-ras + 486 TF}
HZIP-16 I H-ras
HZIP-16 I HSV-2 Bam HI-E

Early passage primary and primary-like fibroblast cells
used in the analysis.
The transformed cell lines
generated from calcium phosphate transfection and
subsequent geneticin selection.
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various cell

lines were analyzed to detect retention of

transfected DNA.

HPV-16

malignant lesions in vivo

DNA is generally integrated in
(Durst et al., 1985) and thus it

was of interest to assess the presence of HPV-16 DNA sequences
in transformed cell lines.

When an EcoRI digest of genomic

DNA was probed with HPV-16 DNA, it was evident all transformed
cell lines retained HPV-16 DNA (Figure 2).

In all cell lines

except cell line 139,·a 9.4 kb HPV- specific hybridizing band
was detected.

Minor bands which also hybridized to the HPV

probe were detected in cell line 140 (7.5 kb band) and cell
line 145 (7.9 kb).

In cell line 139, two HPV-specific bands

(12.5 kb and 6.4 kb) were detected.

Since a recent report

demonstrated that HPV-16 can be detected in oral epithelial
tissue

(Yeudall

and

Campo,

1991),

it

was

important

to

determine if HPV-16 sequences were present in R-30 cells.

As

expected, the HPV probe did not hybridize to R-30 genomic DNA.
The intensity of HPV-16 specific hybridization to DNA prepared
from the various cell lines differed dramatically.

Since the

amount of DNA loaded into each lane was similar, these results
indicated cell line 145 (R-30 transfected with HZIP-16 alone)
and cell line 140 (R-30 cells cotransfected with HZIP-16 and
HSV-2 486 TF) had approximately equivalent amounts of HPV-16
specific DNA.

Cell line 141 (R-30 cotransfected with HZIP-16

and BglII-C) and cell line 139 (R-30 cotransfected with HZIP16 and H-ras) also had equivalent amounts of HPV-16 specific
DNA, however, at lower levels compared to cell lines 140 and

47

Figure 2.

EcoRI digest of DNA from cell lines.

Genomic DNA

was prepared from the various cell cultures (Maniatis et al,
1982), digested with EcoRI and subjected to Southern blotting.
(A) R-30,

(B) 139,

(~) 140,

(D) 141,

(E) 145. The probe was

derived from the Pst I-A and Pst I-B fragments of HPV-16.
Asterisks denote the site of migration of Eco RI digestion
products of HZIP-16.

Molecular size markers, lambda DNA/Hind

III, are shown in kb (23, 9.0, 6.6, 4.4, 2.3, 2.0).
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145.

When uncut genomic DNA of the respective cell lines was

probed

with

HZIP-16

sequences,

the

hybridizing

fragment

migrated with the high molecular weight genomic DNA suggesting
integration had occurred (Figure 3).
HZIP-16 plasmid.

Lane H contains uncut

Both relaxed and supercoiled forms of the

plasmid hybridize to the HPV-16 probe as well as DNA from
transformed and immortalized cell lines while no hybridization
is detected with R-30 and N-16 genomic DNA.

These studies

indicated HPV-16 DNA sequences were retained in all cell lines
and

the

level

of

HPV-16

specific

DNA

varied

among

the

respective cell lines.
To map which regions of the HPV-16 genome were retained
in the various cell lines,

Southern blots were probed with

individual PstI fragments of the HPV-16 genome.

Since all of

the Pst I fragments hybridized to DNA prepared from cells with
HZIP-16 but not control cells, it appears the entire genome of
HPV-16 was retained (Figure 4).

Furthermore, the regions were

retained at different copy levels in the various cell lines.
In

addition

to

seeing

intact

Pst

I

fragments

migrating with control HZIP-16/Pst I/Barn HI),

(fragments
a

number of

different sized bands also hybridized to the probes.

This

agrees with our conclusion that HPV-16 DNA has integrated into
the cellular genome and may also suggest tandem duplications
of the HPV-16 genome occurred.

These studies indicated the

genome of HPV-16 was retained in all cell lines and the copy
level of HPV-16 DNA varied dramatically among the respective
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Figure 3.
from

Analysis of undigested high molecular weight DNA

fibroblast

fibroblast

cell

cell

lines.

Genomic

DNA

prepared

from

lines was subjected to Southern blotting.

Undigested DNA was used to determine integration of HPV-16 DNA
sequences into the high molecular weight DNA species.

The

probe used was the 6.6 kb HPV-16 Barn HI insert from HZIP-16.
Lane (A) N-16,
(G) 181,

(B) R-30,

(H) HZIP-16.

(C) 139,

(D) 140,

(E) 141,

(F) 145,
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figure 4.
(I)

Analysis of HPV-16 DNA in transformed R-30 cells.

High molecular weight DNA was prepared from the various

transformed cells, digested with the restriction enzyme PstI,
and subjected to Southern blot analysis.

Southern blots were

probed with the individual PstI or PstI/BamHI fragments of
HPV-16.

The location.of these probes are presented in (II)

and are above the respective Southern blot.
the figures are not drawn to scale.
respective Pst

I

fragments

The bars above

However,

are drawn to

in

scale.

(II)

the

DNA was

prepared from cell lines:

(A) R-30 (hyperplastic human fibroblasts),
(B) 139 (R-30 cotransfected with HZIP-16 and H-ras,
{C) 140 (R-30 cotransfected with HZIP-16 and HSV-2 486 TF),
{D) 141 (R-30 cotransfected with HZIP-16 and HSV-2 Bgl II-C),
(E) 145 (R-30 transfected with HZIP-16),
(F) C-1 (fibroblasts from a patient treated with cyclosporin),
(G) 181 (R-30 transfected with HZIP-16),
(H) 227 (R-30 cotranfected with HZIP-16, H-ras),
(I) 228 (R-30 cotransfected with HZIP-16 and H-~)-
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cell lines.
HSV-2

DNA

retention

in

fibroblast

cell

lines.

The

retention of HSV-2 DNA sequences in transformed cells was
examined by polymerase chain reaction

(PCR) •

The stable

retention of HSV-2 DNA in transformed cells has not been
consistently
postulated

to

observed
be

and

mediated

(reviewed by MacNab, 1987).

thus

HSV-2

by

"hit

a

transformation
and

run"

is

mechanism

Southern blot analysis using HSV-

2 DNA sequences as probes failed to detect HSV-2 DNA (Figure
5).

However, when high molecular weight DNA was subjected to

PCR analysis using primers derived from 486 TF, retention of
HSV-2 DNA was detected in three cell lines (Figure 6).
three had been transfected with HSV-2 DNA sequences:

All

1) cell

line 140 (HZIP-16 + HSV-2 486 TF), 2) cell line 141 (HZIP-16

+ HSV-2 Bgl II-C) and 3) cell line 268 (HZIP-16 + HSV-2 Bam
HI-E)

(Figure 6).

The amplified band migrated as a 366 bp

fragment and comigrated with the positive control (486 TF).
In contrast, cell line 145 (HZIP-16 alone), cell lines 139 and
227 (HZIP-16 + Ha-ras), R-30 cells and C-1 (primary gingival
cells

treated

with

cyclosporin)

cells

did

not

contain

amplified products which hybridized to the 486 TF probe.
Furthermore, the "no template" negative control lane also did
not contain amplified products which hybridized to 486 TF.
These results demonstrated HSV-2 DNA sequences derived from
486 TF were retained in transformed human cells.
Chromosome analysis of transformed cells.

To examine the

55

Figure 5.

Retention ,of HSV-2 DNA in fibroblast cell lines.

High molecular weight-DNA prepared from fibroblast cell lines,
digested with Eco RI, was analyzed by Southern blot analysis
to determine retention of HSV-2 mtr III sequences.

The HSV-2

mtr III 486 bp Pst I-Sal I fragment was used as the probe.
Lane (A) R-30,
(G) 486 TF.

(B) 139,

(C) 140,

(D) 141,

(E)

145,

(F)

268,

Size markers, lambda DNA digested with Hind III,

are denoted by lines.
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Figure

6.

Polymerase

chain

reaction

transformed fibroblast cell lines.

(PCR)

analysis

of

High molecular weight DNA

was prepared from the respective cell lines, digested with Pst
I

and 1 ug of digested DNA used for

the PCR reaction.

Primers were derived from HSV-2 mtr III 486 TF.
(I)
(II)

Map of HSV-2 mtr III derived primers, 917 and 1262.
Southern blot analysis of PCR reaction using 486 TF as

the probe. Lane (A)
cloned into Pst I

contains 0.1 ug pCPS-1 plasmid (486 TF
and Sal I

sites of pUC19).

contain DNA prepared from cell line 139

Lanes B-I

(B), cell line 140

{C), cell line 141 (D), cell line 145 (E), cell line 227 (F),
cell line 268 {G), R-30 cells (H), and C-1 cells (I).

(J) contains the "no template" control.

Lane

Lane (K) PhiX174 DNA

digested with Hae III (bp) and positions of these fragments
denoted by lines (1353, 1078, 872, 603, 310, 281, 234, 174,
and 118 bp) .
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I.

HSV-2 mtr III Psi 1-C
3'

1133

prim~

216 bp

-

1262

I
Stu I

917

pdmtr: 21 •mer

150 bp

Primer 917: 5' • TCACGGAGGACGACTTTGGGC • 3'
Primer 1262: 5' - GCGTGTTCGGGGTGCTGTGGA - 3'
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chromosomal composition of the various cell lines, karyotype
analysis was performed.
with HZIP-16

alone

Only 50% of the cells transfected

(145)

were

aneuploid and none

aneuploid cells contained more than 100 chromosomes.

of the
However,

90% of the cells derived from lines cotransfected with HZIP-16
and HSV-2 DNA (140 and 141) were aneuploid (Table 3) and at
least 25% of the cel~s had more than 100 chromosomes/cell.
Approximately 50% of R-30 cells cotransfected with HZIP-16 and
H-ras {139) were also aneuploid.
aneuploidy

correlated

with

These studies suggested that
the

presence

of

multiple

transforming agents.
Transformation assays.
capabilities

of

the

various

Anchorage
cell

independent growth

lines

confirm abnormal growth characteristics.

were

analyzed

to

Growth was assessed

by plating cells (PD 30-35 post-geneticin selection) in 0.3%
agarose and scored after 10 days.

Cells cotransfected with

HZIP-16 and regions of HSV-2 mtr III sequences (140, 141 or
268) grew more efficiently in soft agar than cells transfected
with only HZIP-16 (145 and 181)

(Table 4).

Only 3% of cells

transfected with HZIP-16 alone (cell lines 145 and 181) formed
colonies after 10 days.

However, cells cotransfected with

HZIP-16/HSV-2 (140, 141, and 268), had more than 10% colony
formation after 10 days.

As expected, cell line 139 (HZIP-16

and H-ras) also exhibited anchorage independent growth (after
10 days) and R-30 cells did not grow efficiently in soft agar.
Furthermore, saturation density of R-30 cells transfected with

Table 3.

Chromosome number per cell of the transformed cell lines.

Chromosome number in a cell

Cell strain

x

> 200

51-70

71-100

101-200

17

0

3

0

0

139 (HZIP-16/H-ras)

9

0

5

6

0

140 (HZIP-16/486 TF)

2

0

13

5

0

141 (HZIP-16/Bgl II-C)

2

0

11

4

3

10

4

6

0

0

39-50
R-30

145 (HZIP-16)

Karyotype analysis of the various cell cultures was performed at PD 20 or 21
following geneticin selection (except the parental cell R-30).
The number of
chromosomes in a population of cells was determined.

O'I
0

Table 4.

Growth characteristics of transforllled R-30 cells.

Cell line

0.3% agarose
colony forlllation (%) 1

saturation density2

< 1

1

X

10 6

139 (HZIP-16/H-ras)

30

4.9

X

106

140 (HZIP-16/HSV-2 486 TF)

15

5.2

X

106

141 (HZIP-16/HSV-2 Bgl II-C)

15

4.3

X

106

268 (HZIP-16/HSV-2 Bam HI-E)

15

5.1

X

106

R-30

~

145 (HZIP-16)

3

2.4 X 106

181 (HZIP-16)

4

2.7

X

10 6

±
±
±
±
±
±
±

1

X

105

1.3

X

105

1.8

X

105

2.0

X

105

1.5

X

105

0.6 X 105

1.1

X

105

The ability of R-30 cells and the various transformed derivatives of R-30 cells were
analyzed for growth in soft agar.
11 x 105 cells of each line were plated in medium containing 0.3% agarose and scored after
10 days.
Numbers indicate the percentage of cells which formed colonies.
To be
considered a colony, the diameter of the colony was at least 1 mm.
2
Saturation density was the number of cells/100 mm dish at confluence. Plates were seeded
with 3 x 105 cells and the various cultures were fed three times a week. After two weeks
in culture, the cells were trypsinized and counted using a hemacytometer.
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HZIP-16 alone {145) was lower than cells cotransfected with
HZIP-16/HSV-2 or HZIP-16/H-ras.

When the individual cell

lines were injected subcutaneously into nude mice {5 x 106
106

s x

cells/animal} ,

tumor

formation

observed after 6 weeks {Table 5).

was

not

-

readily

Transitory nodules were

observed in animals injected with some of the transformed
cells.

However, these nodules regressed after several weeks.

This may imply the cell lines were not fully transformed or
the transformed cells were rejected by the mouse.

In summary,

anchorage independent growth was more efficient when R-30
cells were cotransfected with HZIP-16 and HSV-2 DNA sequences
or H-ras.
Comparison of R-30 and N-16 cells.

Since R-30 cells were

immortalized more efficiently by HZIP-16

than N-16 cells, a

comparison of the two cell types was subsequently made.
obvious

differences

characteristics

{FACS,

growth

or

rates,

unpublished data}.
cell

types

were

detected

90° vs.

saturation

in

No

morphological

forward scattering ratios),
densities

{V.

Veerisetty,

In contrast, karyotype analysis of the two

revealed

that

all

R-30

cells

have

a

stable

chromosomal translocation between chromosome 8 and chromosome
18 {Figure 7).

Approximately 15% of R-30 cells contained more

than 50 chromosomes.
Since the c-myc protooncogene is present on chromosome 8
{Neel et al., 1982) and alterations of this gene have been
associated with HPV-16 and transformation {Riou et al., 1987,

Tables.

Twnorigenicity analysis of fibroblast cell lines.

Cell line

Twnor formation

R-30

0/3

139 (HZIP-16/H-ras)

0/3

140 (HZIP-16/HSV-2 486 TF)

0/3

141 (HZIP-16/HSV-2 Bgl II-C)

0/3

145 (HZIP-16)

0/3

268 (HZIP-16/HSV-2 Bam HI-E)

0/3

Tumorigenic potential of fibroblast cell lines was analyzed for
production of palpable tumors.
5 x 106 cells were injected
subcutaneously into ,ny/nu mice. Eight weeks post injection, mice were
anesthetized and observed for the presence of lesions.
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Figure 7.

Karyotype analysis of N-16 and R-30 cells.

(I)

Arrows indicate aberrations in chromosome 8 and 18 of R-30
cells.
18.

All R-30 cells contained the aberrant chromosome 8 and

(II)

cells.

Chromosome number in a population of N-16 and R-30

The modal chromosome number for N-16 cells and R-30

cells was 46.
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ourst et al., 1987, Crook et al., 1990), it was important to
examine

c-myc

expression

and

organization

in R-30

cells.

Genomic DNA was prepared from R-30 cells, R-30 derived cell
lines or N-16 cells and southern blot analysis performed.

Two

c-myc probes, a 1.6 kb Sac I fragment of the 5'-untranslated
region and a 420 bp Pst I fragment of exon 2, were used to
detect aberrations in gene organization of c-myc DNA.

No

detectable rearrangements were observed in any of the R-30
cell lines when compared to N-16 cells (Figure 8).
steady state levels of c-myc RNA expression,
protection analysis was performed.

To measure

ribonuclease

An in vitro transcript was

synthesized from the 420 bp Pst I fragment of exon 2 and used
as a probe.

As expected, a ribonuclease resistant fragment

approximately 420 nucleotides was detected when cellular RNA
was hybridized to an antisense c-myc transcript (Figure 9).
R-30 cells and transformed R-30 cells clearly contained higher
steady state levels of c-myc RNA when compared to N-16 cells
or

C-1

cells

(early

passage

human

gingival

fibroblasts

prepared from a patient treated with cyclosporin).

When the

radioactivity in the c-myc band was quantified, R-30 cells as
well as transformed R-30 cells consistently contained at least
three fold higher levels of c-myc RNA compared to either N-16
or C-1 cells.

These results demonstrated R-30 cells contained

higher steady state levels of c-myc RNA and suggested the
translocation of chromosome 8 was related to overexpression.
Examination of the human p53 gene in fibroblast cell
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Figure 8.

c-myc gene organization in fibroblast cell lines.

High molecular weight DNA was prepared from fibroblast cell
lines,

digested with restriction enzymes and Southern blot

analysis was performed •

.

Size markers,

lambda DNA digested

with Hind III, are denoted by lines.
(I)

Genomic DNA was digested with Pst I and probed with the

1.6 kb Sac I fragment of the 5'-untranslated region of c-myc.
Lane (A) N-16,

(B) R-30,

(C) 139,

(D) 140,

(E) 141,

(F) 145,

(G) 268.
(II)

Genomic DNA was digested with Eco RI\Kpn' I and probed

with the 420 Pst I fragment of exon 2 of c-myc.
16,

(B) R-30,

(C) 139,

(D) 140,

(E) 141,

(F) 145,

Lane (A) N(G) 268.

II

O'\
00
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Figure 9.

Ribonuclea~e protection analysis of N-16, c-1 and

R-30 derived cell lines.

32

P-UTP labelled RNA probes were

synthesized from the 420 bp Pst I fragment of c-myc (exon 2).
(A)

Antisense SP6 probe contained the strand complementary to

the c-myc mRNA coding strand while the sense T7 probe was the
same as the coding strand. Lane (a) N-16,
(d)

145,

(e)

C-1.

probed with B-actin.
145,

(e) C-1.

(B)

(b) R-30,

(c) 140,

Total cellular RNA of cell lines

Lane (a) N-16,

(b) R-30,

(c) 140,

(d)

c-Myc
Ant1sense

ABC
420

Sense

DE

ABC

DE

~

B-actin
Ant1sense

A

B

C

D

E

350~

-.J
0
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lines.

The E6 oncoprotein of HPV-16/18 is able to bind and

promote degradation

of

the

tumor

suppressor protein,

(Werness et al., 1990, Scheffner et al., 1990).
to act as a suppressor of transformation

p53

p53 is able

(Eliyahu et al.,

1989, Finley et al., 1989, Hinds et al., 1989, Scheffner et
al., 1990).

To determine if human p53 (Hp53) is rearranged in

transformed fibroblast~, organization of this tumor suppressor
gene was examined.

A ·1.5 kb Xba I-Sma I fragment of a 2.1 kb

cDNA clone of hp53 was used as a probe.

High molecular weight

DNA was prepared from fibroblast cell lines and Southern blot
analysis

was

performed

(Figure

10).

The

Hp53

gene

was

detected in all cell lines, however, no alterations of this
gene were detected when compared to R-30, HPV-16 immortalized
and HPV/HSV-2 transformed.
Generation of transformed keratinocyte cell lines.

To

study interactions between HSV-2 and HPV-16 or HPV-18 in their
natural host, human epithelial cells, genital keratinocytes
previously

immortalized

with

HPVs,

were

transfected

plasmids containing HSV-2 mtr III sequences.

with

HPV-16 (FEPL)

and HPV-18 (FEA) immortalized cell lines were generated from
primary human foreskin keratinocytes
1988, Kaur et al.,

1989)

(Figure 11).

(Kaur and McDougall,
To generate HPV-16

immortalized cell lines (FEPL) a plasmid containing the HPV-16
E6,

E7

and

keratinocytes

LCR

were

used

to

immortalized

(Kaur and McDougall,

1988).

normal

human

FEPL cells were

subsequently utilized as parental cells in this transfection

72

Figure 10.
(I)

Hp53 gene organization in fibroblast cell lines.

Schematic diagram of 2.1 kb Barn HI cDNA hp53 insert.

The

1.5 Xba I-Sma I fragment was used as the probe in all hp53
southern blotting analysis.

The 2 .1 kb Barn HI cDNA hp53

insert was cloned into pBR322.

Translational start and stop

codons indicated by arrows.
(II)

Genomic DNA prepared from fibroblast cell lines, double

digested with Eco RI and Xba I,
blotting analysis.
(E)

145,

(F) C-1,

was subjected to Southern

Lane (A) R-30, (B) 139, (C) 140, (D) 141,
(G)

181,

(H)

268,

(I)

1.5 kb Xba I/Sma I

hp53 fragment. The probe used for hybridization was the 1.5 kb
hp53 fragment.

Size markers, lambda DNA digested with Hind

III are denoted by lines.
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Figure 11.

Schematic map of HPV-16 and HPV-18.

(I)

Map of HPV-16 inpicating the 3.4 kb fragment of HPV-16

DNA

retained

in

a

tumor

clone

(black

boxes)

used

to

immortalize primary genital keratinocytes (Kaur et al, 1989).
These HPV-16 immortalized keratinocytes were subsequently used
to

generate HSV-2/HPV-16

cells).

cell

lines

(designated

as

FEPL-

Restriction enzyme sites are K (Kpn I), H (Hine II),

S (Stu I), E (Eco RI) and B (Barn HI).
(II) Restriction map of HPV-18.

pHPV18,

genome and pBR322 vector sequences,

containing HPV-18

was used to transfect

primary genital keratinocytes (Kaur and McDougall, 1988).

The

resulting HPV-18 immortalized cell lines were used to generate
HSV-2/HPV-18 cell lines (designated as FEA- cells).
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analysis.

HPV-18 immortalized (FEA) cells were generated by

cotransfecting primary human epithelial cells with a plasmid
containing the entire HPV-18 genome and pSV2neo and selecting
for growth in geneticin (Kaur and McDougall, 1988).

FEA cells

were also used as parental cells in this analysis.

Both cell

lines were maintained in culture over one year prior to these
studies.
To test for morphological transformation of FEPL and FEA
cells, plasmids containing HSV-2 DNA sequences derived from
mtr III (Jones et al., 1986) were transfected into parental
cell lines.

Additionally, a plasmid containing an activated

H-ras gene, pEJ6. 6, was transf ected into immortalized cells to
serve

as

a

positive

control

(Matlashewski et al., 1987).

for

cooperation

with

HPVs

Table 6 shows the results from

the transfection experiments using HPV-16 (FEPL) and HPV-18
(FEA) immortalized cells.
performed.

Three independent experiments were

G418 selection was utilized because parental HPV-

immortalized cells have lost their geneticin resistance and
thus are sensitive to drug selection.

Stable cell lines were

obtained with all transfectants.

FEPL and FEA cells had

similar transfection efficiencies.

No single HSV-2 mtr III

region was more efficient for transforming either FEPL or FEA
cells.

The overall efficiency of Experiment 1 from Table 6

was low compared to subsequent experiments.

In summary,

results demonstrated that geneticin resistant cell lines could
be obtained from HPV immortalized cells transfected with HSV-2

Table 6.

'Rransfection analysis of illllortalize4 keratinocytes.

FEPL (RPV-16)

FEA (RPV-18)
Exp. 1

Exp. 2

Exp. 3

Exp. 1

Exp. 2

Exp. 3

HSV-2 486TF
HSV-2 Pst I-C

2

5

8

0

7

10

1

5

6

1

6

8

HSV-2 Bam HI-E
Ha-ras
pSV2neo

1

8

6

1

7

3

4

9

0

8

0

2

4

0

5

12
15
10

HPV-16 or -18 immortalized genital keratinocytes (5 x 105 cells/60 mm dish) were
transfected with 10 ug plasmid DNA using the polybrene transfection procedure (Rhim
et al, 1986) followed by geneticin selection (50 ug/ml for FEA cells, 500 ug/ml for
FEPL cells). Values indicate the number of geneticin resistant colonies.
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mtr III derived sequences.
Growth characteristics of transformed cell lines.

A

comparison of HPV immortalized and HPV/HSV-2 transformed cell
lines was undertaken to determine if differences existed.
subtle morphological differences between HPV-16 immortalized
and

HPV-16/HSV-2

(Figure 12).
organized

transformed

keratinocytes

were

observed

Transfor~ed cells were irregularly shaped, less

compared

morphological

no

immortalized

differences

were

cells.

seen

Furthermore,

between

primary

keratinocytes and an immortalized FEPL clone in Figure 13.
Differences were more apparent in transformed FEPL cells than
FEA cells.

Saturation density analysis indicated that FEPL or

FEA cells transformed by mtr III DNA fragments contained two
times the number of cells after one week in culture than the
immortalized counterpart (Table 7) •

HPV /H-ras cell lines (FEA

or FEPL) behaved similarly to HPV/HSV-2 transformants while
HPV immortalized cells with pSV2neo had saturation density
values similar to the HPV immortalized parental cells.
To analyze anchorage independent growth capabilities of
the various cell lines, growth was assessed by plating cells
in 0.3% agarose and scoring after 10 days.

All three HPV-

16/HSV-2 transformed cell lines grew at similar efficiencies
in soft agar.

Immortalized FEPL cells were able to grow with

low efficiency in soft agar, however, not at the rate of the
transformed

counterparts.

In

contrast,

transformed cells did not grow in soft agar.

the

HPV-18/HSV-2

Furthermore, FEA
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Figure 12.

Photograph.of immortalized FEPL cells (I) and FEPL

cells transformed with the HSV-2 mtr III Bam HI-E fragment
(II) .
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Figure 13.

Primary keratinocytes immortalized with HPV-16.

Photograph of immortalized HPV-16 geneticin resistent colony
seen along with primary keratinocytes.
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Table 7.

Growth characteristics of keratinocyte cell lines.

Cell line

0.3% agarose
colony fomtion 1

saturation density2

106

FEA-N (HPV-18)

< 1

1. 2

ATF-1 (HPV-18/486 TF)

< 1

2. 8 X 106

APC-1 (HPV-18/Pst I-C)

< 1

ABE-1 (HPV-18/Bam HI-E)

< 1

.2 . 0.

X

X

106

2. 6 X 106

5

3. 2

X

10 6

PTF-1 (HPV-16/486 TF)

15

6.3

X

106

PPC-1 (HPV-16/Pst I-C)

15

5 •9

X

106

PBE-1 (HPV-16/Bam HI-E)

15

6.4 X 10 6

FEPL-N (HPV-16)

±
±
±
±
±
±
±
±

6. 5

X

105

4. 4 X 105
8 . 8 X 105

6. 3

X

105

8. 7

X

105

3 •8

X

105

5 •8

X

105

4.5 X 10 5

Growth characteristics of keratinocyte cell lines were analyzed for anchorage
independent growth and saturation density rates.
1
1 x 105 cells of each cell line were plated in medium containing 0.3% agarose and
scored after 10 days. Numbers indicate the approximate percentage of cells which
formed colonies. Colonies were counted if size was at least 1 mm.
2
Saturation density was the number of cells/100 mm dish at confluence. Plates were
seeded with 3 x 105 cells and after one week in culture, cells were trypsinized and
counted using a hemocytometer.
00

w

84

illlillortalized cells did not grow efficiently in soft agar
(Table 7).

In summary, slight differences in morphology were

detected in HPV-16/HSV-2 transformed cell lines but these
differences were not readily seen in HPV-18/HSV-2 cell lines.
Morphology

changes

were

clearly

apparent

keratinocytes were immortalized with HPVs.

after

primary

Both HPV-16 and

HPV-18 transformed cell lines had saturation density values
twice as great as their immortalized counterpart.

Only HPV-

16/HSV-2 transformed cells exhibited anchorage independent
growth capabilities.
HPV DNA retention in keratinocyte cell lines.

FEA and

FEPL cell lines have one to two copies of integrated viral
genomes/cell (Kaur and McDougall, 1988, Kaur et al., 1989).
This study was conducted to examine the organization of HPV
DNA after the cells were transformed by HSV-2 mtr III or Hras.

High molecular weight DNA from various cell lines was

analyzed to detect rearrangments of HPV viral DNA by Southern
blot analysis.
Genomic DNA from FEPL cell lines, containing only 3.4 kb
of HPV-16 sequences, was hybridized to three separate probes:
a large 6.6 kb probe spanning the entire HPV-16 early genome
(excised from HZIP-16, does not include the late region), a
1. 0

kb probe

covering the

LCR,

E6

and

E7

ORFs

(Pst

I-B

fragment of HPV-16) and a 2.6 kb probe containing the El, E2
ORFs (Kpn I/Hine II fragment of HPV-16).

Two HPV-16 specific

fragments were detected when Pst I digested genomic DNA was
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probed with the 6. 6 kb HPV-16 probe

(Figure 14).

Pst I

digestion of 3.4 kb HPV-16 sequences retained in FEPL cells
yields 4 fragments: 2 which contain the early HPV-16 regions
and 2 which span the late HPV-16 regions.

The latter two

bands would not be detected with the 6. 6 kb probe.

These

results suggest the early region of the 3.4 kb sequence is
intact.

Hybridizatioq with the 6.6 kb probe did not show any

rearrangments of the HPV-16 genome.

Neither the 1.0 kb Pst I-

B (Figure 15) nor the 2.8 kb Kpn I-A (Figure 16) revealed any
rearrangements of the HPV-16 DNA in transformed cell lines.
Malignant lesions which contain HPV DNA integrated into the
cellular genome frequently have only a portion of the viral
DNA present (Durst et al., 1985).

Viral DNA usually consists

of an intact E6, E7 and LCR (Matsukura et al., 1986, Pater and
Pater,

1985,

Seedorf et al.,

1987). The Kpn I-A probe was

utilized to detect possible rearrangments of viral DNA since
HPV integration occurs within the El/E2 ORFs and alterations
generally occur in this region.
HPV-16

DNA were

detected

in

However, no rearrangments of
the

transformed

cell

lines,

although, changes in the E6 and E7 genes of HPV would not be
expected to occur.
To determine if rearrangements of the HPV-18 DNA were
present

in transf armed cells,

performed.

Southern blot analysis was

High molecular weight

DNA prepared

from

FEA

derived keratinocyte cell lines was hybridized to a 7.9 kb
HPV-18 probe, spanning the entire genome of HPV-18.

Figure 17
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Figure 14.
lines.

Organization of HPV-16 DNA in FEPL-derived cell

High molecular weight DNA was prepared from FEPL-

derived cell lines,

digested with Pst I

analysis was performed.

DNA was probed with the 6.6 kb Barn HI

HPV-16 insert of HZIP-16.
PPC-1,

(D) PPC-2,

HI fragment.

and Southern blot

(E) PBE-2,

Lane {A)

FEPL-N,

{F) Pneo,

(B)

PTF-2,

{C)

(G) 6.6 kb HPV-16 Barn

size markers, lambda DNA digested with Hind III,

are denoted by lines.
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A

B

C

D

E

F

G
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Figure 15.

Retention of E6, E7 ORFs in FEPL cell lines.

High

molecular DNA prepared.from FEPL derived cell lines was double
digested with Pst I and Eco RI and subjected to southern blot
analysis.

DNA was probed with the Pst I-B fragment of HPV-16

which spans, ORFs E6, E7 and the LCR.
PTF-2,

(C)

PPC-1

(D)

PPC-2,

(E)

Lanes (A) FEPL-N,

PBE-1,

(F)

Pras.

(B)
Size

markers, lambda digested with Hind III, are denoted by bars.
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A

•

B

••

C

D

E

F
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Figure 16.

Retention of ORF El in FEPL cell lines.

Genomic

.

DNA was prepared from FEPL derived cell lines, double digested
with

Pst

performed.

I

and

Eco

RI

and

blot

analysis

was

The 2.8 kb Kpn I-A fragment, spanning the entire

El ORF was used the probe.
PPC-1,

Southern

(D) PPC-2,

(E) PBE-1,

Lane (A) FEPL-N,
(F) Pras.

(B) PTF-2,

(C)

Size markers, lambda

DNA digested with Hind III, are denoted by lines.
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Figure

17.

Rearra~gment

keratinocyte cell

lines.

derived cell lines,
Southern blotting.
the probe.

of

HPV-18

DNA

in

transformed

Genomic DNA prepared from FEA-

digested with Pst I,

was subjected to

The 7.9 kb HPV-18 genome was utilized as

Lane (A) FEA-N,

(B) ATF-1,

(C) ATF-2,

(D) APC-1,

(E) ABE-1, (F) ABE-2, (G) Aras, (H) Aneo, (I) 7.9 kb fragment
of HPV-18.

Size markers, lambda DNA digested Hind III, are

designated by lines.
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shows

the

results

of

the

Southern

blot

analysis.

Rearrangements of viral DNA were detected in transformed cells
(lanes B-F) when compared to immortalized (lane A) and HPV/Hra.§.

(lane

G)

cell

lines.

Deletions

were

detected

in

transformed cells with the loss of a 2.3 kb band in APC-1
(lane D)

and ABE-1

(lane F).

In contrast,

cell line APC-2

contained an additionai 2.6 kb hybridizing fragment (lane E).
similar results were seen when genomic DNA was digested with
Hine II (Figure 18).

However, when genomic DNA of FEA cell

lines was hybridized to a HPV-18 probe spanning E6, E7 and
LCR, no changes were detected (Figure 19) as expected since
this region remains intact in a majority of HPV-18 cell lines.
In summary, no detectable changes were present in the HPV-16
DNA of transformed cell lines.

However, rearrangments were

detected in the HPV-18 DNA after FEA cells were transformed by
HSV-2 mtr III sequences.
Retention of HSV-2 DNA sequences in transformed cell
lines.

HSV-2

DNA

sequences

have

not

consistently

been

detected in transformed cells, however, significant evidence
has demonstrated a correlation between HSV-2 infection and
malignant transformation (DiLuca et al., 1989, Hildesheim et
al., 1991).

The inconsistent nature of HSV-2 DNA retention

has led to a
transformation

"hit and run" hypothesis for HSV-2 mediated
(reviewed by MacNab,

1987).

Southern blot

analysis using HSV-2 DNA sequences as probes failed to detect
viral DNA (Figure 20) .

Since PCR analysis is a more sensitive

95

Figure 18.

Hine II digest of DNA from FEA-derived cell lines.

Genomic DNA was prepared from FEA-derived cell lines, digested
with Hine II and subjected to Southern blotting.
FEA-N,
(G)

(B) ATF-1,

ABE-2,

genome.

Lane

(A)

(C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1,

(H) Aras.

The probe used was the 7.9 kb HPV-18

Molecular size markers, lambda DNA digested with Hind

III, are denoted by lines.
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Figure 19.
lines.

Retention of HPV-18 sequences in keratinocyte cell
High

molecular

weight

DNA

prepared

from

HPV-18

keratinocyte cell lines, digested with Pst I, was subjected to
southern blotting analysis.
spanning the HPV-18 LCR,
ATF-1,

(C) ATF-2,

E6,

(D) APC-1,

A 2. 4

Eco RI/Bgl

E7 ORFs.
(E) APC-2,

Lane

(A)

(F) ABE-1,

I

fragment

FEA-N,

(B)

(G) Aras.

Size markers, lambda DNA digested with Hind III, are denoted
by lines.
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Figure 20.

Retention of
,, HSV-2 DNA sequences in PEA-derived

cell lines.

High mo].ecular weight DNA prepared from FEA

derived keratinocyte cell lines, digested with Eco RI,

was

analyzed by Southern blot analysis to detect retention of HSV2 DNA sequences.

The HSV-2 mtr III

fragment (486 TF) was used as the probe.
ATF-1,
(H)

(C) ATF-2,

Aneo,

(I)

(D) APC-1,

486 TF.

(E) APC-2,

486

bp Pst

I-Sal

I

Lane (A) FEA-N, (B)
(F) ABE-1,

Molecular size markers,

digested with Hind III, are denoted by bars.

(G) Aras,
lambda DNA
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assay to detect DNA sequences present in very low quantities,
this technique was employed.

High molecular weight DNA

digested with Eco RI was subjected to PCR analysis using
primers derived from HSV-2 486 TF.

Analysis of FEPL and FEA

derived cell lines indicated HSV-2 retention in only three FEA
cell lines {Figure 21).
retained HSV-2
retained HSV-2

None of the 5 HPV-16/HSV-2 cell lines

whereas, 3/5 HPV-18/HSV-2 cell
•
DNA sequences, ATF-2, APC-2, ABE-2.

DNA,

amplified band migrated as a 366 bp fragment.

lines
The

Neither the

immortalized keratinocyte cell lines, normal keratinocyte DNA
nor the HPV/H-ras had 486 TF hybridizing fragments.

These

results demonstrated HSV-2 DNA sequences were present in low
concentrations in some transformed cell lines.
Analysis of cellular protooncogene c-myc in transformed·
keratinocyte cell lines.

Earlier studies have demonstrated

that integration of high risk HPVs occurs near the c-myc
protooncogene or led to disruption of c-myc gene {Riou et al.,
1987, Durst et al., 1987, Crook et al., 1990).

To determine

if the c-myc locus was disrupted after FEA or FEPL cells were
transformed by HSV-2 mtr III, organization of the c-myc gene
was examined.

Two c-myc probes, a 1.6 kb Sac I fragment of

the 5' untranslated region and a 420 bp Pst I fragment of exon
2 were utilized to detect alterations in gene organization of
c-myc DNA.

Figures 22 and 23 show t~e Southern blot results

when high molecular weight DNA was digested with restriction
enzymes {HPV-16, Pst I; HPV-18, Hine II) and hybridized to the
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Figure

21.

Polymerase

chain

reaction

transformed keratinocy~e cell lines.

(PCR)

analysis

of

High molecular weight

DNA was prepared from the respective cell lines, digested with
Pst I and 1 ug of digested DNA was used for the PCR reaction.
Primers were derived from HSV-2 mtr III 486 TF.

Lane

(A)

contains 0.1 ug pCPS plasmid (486 TF cloned into Pst I and Sal
I sites of pUC19).

Lanes B-Q contains DNA prepared from FEPL

and FEA derived cell lines.

Lane (B) PTF-1,

PPC-2,

(G) Pras,

(J)

(E) PBE-1,

APC-1,

Aneo,

(K)

(F) PBE-2,

APC-2,

(L)

ABE-1,

(M)

(H) Pneo,
ABE-2,

(P) normal primary keratinocyte DNA,

control.

The

probe

used was

the

486

(C) PPC-1,

TF

(N)

(D)

(I) ATF-2,
Aras,

(0)

(Q) "no template"
fragment.

Bars

indicate size markers, PhiX174 DNA digested with Hae III (bp)
(1353, 1078, 872, 603, 310, 281, 234, 174, and 118).
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Figure 22.
lines.

c-myc gene organization in FEPL-derived cell

High molecul~r weight DNA from FEPL cell lines was

prepared and digested with Eco RI and Pst I,
Southern blotting analysis.
PPC-1,

(D)

PPC-2,

(E)

Lanes (A) FEPL-N, (B) PTF-2, (C)

PBE-2,

(F)

Pneo,

untranslated region (I) or exon 2 in (II).
hybridization were

(I)

followed by

(G)

either

5'-

Probes used in

a 1.6 kb Sac I fragment of the 5 1 -

untranslated region and (II) a 420 bp Pst I fragment of exon
2.

Size markers,

denoted by lines.

lambda DNA digested with Hind III,

are

II
A

BC

DE

FG

A

BC

DE

FG

•

I-'
0

Vl

106

Figure 23.
High

c-myc gene organization in FEA-derived cell lines.

molecular

keratinocytes

weight

and

FEA

DNA

was

prepared

derived . cell

lines,

from

primary

digested

with

restriction enzymes, and Southern blot analysis was performed.
Size markers, lambda DNA digested with Hind III, are denoted
by lines.
(I)

Genomic DNA was digested with Pst I and probed with the

1.6 kb Sac I fragment of the 5'-untranslated region of c-myc.
Lane (A) normal primary keratinocyte DNA (NKD), (B) FEA-N, (C)
ATF-1,
(II)

(D) ATF-2,

(E) APC-2,

(F) ABE-1,

(G) ABE-2,

Genomic DNA was digested with Hine II and probed with

the 420 bp Pst I fragment of exon 2 of c-myc.
(B)

(H) Aras.

FEA-N,

ABE-2,

(C) ATF-1,

(H) Aras.

(D) ATF-2,

(E) APC-2,

Lane (A) NKD,
(F) ABE-1,

(G)

II

I
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c-myc probes.

No detectable rearrangments were observed in

any cell lines, either HPV-16 or HPV-18 derived.

Furthermore,

c-myc organization of immortalized and transformed cell lines
was compared to primary keratinocyte DNA and no changes were
apparent.

Multiple restriction digests (Eco RI, Eco RI/Pst I,

Eco RI/Kpn I) were anaylzed.
Analysis of hp53 in transformed keratincyte cell lines •
•
Mutations in the tumor suppressor gene, p53, have been
associated with hyperproliferation and chromosomal instability
(Hudson et al., 1990, Woodworth et al., 1990).

The E6 early

protein of HPV-16/18 binds the p53 gene product and promotes
degradation of the cellular protein (Scheffner et al., 1990).
Thus, it was of interest to understand what role this cellular
gene may have in the pathogenesis of HPV/HSV-2 transformed
cell lines.
analyzed.

Hence, gene organization of human p53 (hp53) was
A 1.5 kb Xba I-Sma I fragment from the hp53 cDNA

clone was used as probe since

it yielded clear results.

Southern blot analysis indicated no apparent aberration in
hp53 gene organization of either FEPL derived (Figure 24) or
FEA derived

(Figure 25)

cell lines.

Multiple digests of

genomic DNAs were performed and did not detect rearrangments
(data not shown) •
tumor

suppressor

In summary,
gene

were

rearrangements of the hp53
not

apparent

in

HPV/HSV-2

transformed cell lines when compared to HPV immortalized cell
lines.
RNA analysis of transformed cell lines.

Northern blot

109

Figure 24.

Hp53 gene organization in FEPL-derived cell lines.
1

Genomic DNA was prepar~d from FEPL derived cell lines, double
digested with Eco RI and Pst I and Southen blot analysis was
performed.

The probe used for hybridization was the 1.5 kb

Xba I-Sma I fragment of hp53.
PPC-1,

(D) PPC-2,

markers,
lines.

(E) PBE-2,

Lane (A) FEPL-N, (B) PTF-2, (C)
(F) Pneo,

(G) hp53 probe.

lambda DNA digested with Hind III,

Size

are denoted by

110

111

Figure 25.

Hp53 gene organization in FEA-derived cell lines.

'
Southern blotting analysis
was performed using genomic DNA
prepared from FEA cell lines and digested with Pst I.
probed with the 1. 5 kb Xba I-Sma I fragment of hp53.

DNA was
Lane (A)

FEA-N, (B) ATF-1, (C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1,
(G)

Aras,

(H)

Aneo.

Molecular

size markers,

digested with Hind III, are denoted by lines.

lambda

DNA
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analysis

was

performed

to

determine

if

RNA

transcripts

differed in HPV immortalized and HPV/HSV-2 transformed cell
lines.

Total cellular RNA was hybridized to probes spanning

the HPV-16 or -18 E6 and E7 ORFs.

Three transcripts were

detected ranging in size from 4.5 kb to 1.8 kb (Figure 26).
However,

no

specific

differences

were

observed

between

immortalized and transformed cell lines •
•
Tumorigenicity analysis. To determine if the respective
cell lines could induce tumors in animals, cell lines were
injected

subcutaneously

cells/animal).
lesions.

into

nu/nu

nude

mice

(

5

x

106

Mice were monitored weekly for the presence of

Eight weeks post injection, mice were anesthesized

and lesions excised.

FEPL (HPV-16)

cells transfected with

HSV-2 mtr III sequences were all able to form abnormal tumorlike epithelial

lesions

immortalized cells.

(Table 8),

in contrast to HPV-16

FEPL cells transfected with H-ras also

formed tumor-like lesions however, they were not invasive, as
Matlashewski
cells.

et al.,

(1987)

had demonstrated with rodent

Histological analysis of tumor-like lesions with HPV-

16/HSV-2 mtr III sequences indicated benign epithelial cysts.
Typically these tumor-like lesions were present 4 weeks post
injection.
FEA (HPV-18) cells were unable to produce any lesions.
Tumor formation in mice injected with HPV-18/HSV-2 mtr III
cell lines was not readily observed 8 weeks post injection.
Lesions were not observed even in FEA cells transfected with
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Figure

26.

HPV

expression

in transformed keratinocytes.

Total cellular RNA was extracted from keratinocyte cell lines
using the guanidine thiocyanate/cesium chloride method and
subjected to Northern blot analysis.

Ten ug of total RNA was

loaded per lane in a~% formaldehyde gel.
(III), lane (A) FEPL-N,
APC-2,

(F)

ATF-2.

In (I),

(B) PPC-1, {C) PTF-1,

(II), and

(D) FEA-N,

(E)

28S and 18S ribosomal RNA markers are

shown.
(I)

Northern blot analysis of FEPL- cells (HPV-16) and FEA-

cells (HPV-18).

The HPV probe used was derived from HPV-16,

the Baro HI-Pst I fragment covering E6, E7 and LCR.
(II)

Northern blot analysis FEPL- and FEA- cell lines.

HPV probe used was derived from HPV-18,

The

the Baro HI-Eco RI

fragment covering E6, E7, LCR and 2/3 of El.
(III)

Northern blot analysis of FEPL- and FEA- cells using

actin as a probe to ensure equal levels of RNA were loaded in
each lane.

,

A

B

C

D

E

II.

F

~

28S

~

18S

A

B

C

D

E

F

~28S

~•ss

III.

ABCDEF
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Table

a.

Tumorigenicity analysis of keratinocyte ce11 1ines.

Cell Line

Tumor Formation

Type of Lesion

FEPL-N (HPV-16)

0/5

PTF-1 (HPV-16/486 TF)

2/5

epithelial cyst

PPC-1 (HPV-16/Pst I-C)

5/7

epithelial cyst

PBE-1 (HPV-18/Bam HI-E)

4/5

epithelial cyst

Pras (HPV-16/H-ras)

4/5

epithelial cyst

FEA-N (HPV-18)

0/5

ATF-2 (HPV-18/486 TF)

0/5

APC-2 (HPV-18/Pst I-C)

0/5

ABE-2 (HPV-18/Bam HI-E

0/5

Aras (HPV-18/H-ras)

0/5

Hela (HPV-18 cervical
carcinoma)

2/2

anaplastic
carcinoma

Tumorigenic potential of keratinocyte cell lines was analyzed for production of
palpable tumors. 5 x 106 cells were injected subcutaneously into nu/nu mice. Eight
weeks post injection, mice were anesthetized and observed for the presence of
lesions. Lesions were classified based on histological analysis.
~
~
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H-ras.

However, when Hela cells, HPV-18 containing cervical

carcinoma cell line,

were injected into nude mice,

appeared after two weeks and grew progressively.
analysis

of

Hela

lesions

indicated

tumors

Histological

anaplastic

carcinoma.

Figure 27 shows the tumor-like lesions seen upon injection of
HPV-16/HSV-2

Pst

I-C cells

into mice.

These

tumor-like

lesions were similar1 with other HSV-2 mtr III

sequences.

Figure 28 demonstrates the histological analysis of normal
adjacent tissue

(muscle)

(I),

tumor-like lesions

Hela induced anaplastic carcinoma (III, IV).

(II), and

The tumor-like

epithelial lesions formed circular cysts.

These contained

actively growing, keratin producing cells able to enlarge the
lesion with time.
tumor

showed

carcinoma.
phases

Histological analysis of the Hela induced

characteristics

indicative

of

an

invasive

Numerous multinucleated cells, abnormal mitotic

were

visible

invasive cells.

along

with

necrotic

cells

near

the

Figure 29 shows the gross anatomy of the Hela

infected mouse, enlarged area of tumor formation and size of
tumor.

In summary, HPV-16/HSV-2 cell lines were able to form

benign

epithelial

cysts when

injected

into

nude mice

in

contrast to HPV-18/HSV-2 cell lines where lesions were not
readily apparent.

This may imply a propensity for HPV-16,

more commonly found in cervical carcinoma biopsies than HPV18, to interact with transforming agents such as H-ras and
HSV-2

mtr

III

sequences

epithelial lesions.

in

the

induction

of

tumor-like

In addition, the inability of HPV-18/HSV-
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2 or H-ras to produce lesions may indicate rejection of these
human cells by the mouse.
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Figure 27.
cyst.

Photograph of HPV-16/HSV-2

induced epithelial

Arrows indicate tumor-like lesion observed after 8

weeks post injection of 5 x 10
into nu/nu mouse.

6

HPV-16/HSV-2 Pst I-C cells

The tumor-like lesion was small and white.
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Figure 28.

Histological analysis of (I) normal muscle tissue,

(II) tissue from the tumor-like lesion induced by HPV-16/HSV-2
Pst I-C cells,
carcinoma.

(III)
Arrows

tissue from Hela induced anaplastic
indicate

invasive

cells.

(IV)

Magnification of Hela tumor showing multinucleate cells and
abnormal mitotic phases.
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Figure 29.

Gross anatomy of Hela induced tumor.

(I) 5 x 10

cells were injected subcutaneously into nu/nu mice.
indicates large tumor observed 8 weeks post injection.

6

Arrow
(II)

Mice were anesthesized 8 weeks post injection and the tumor
was excised.
from

nu/nu

carcinoma.

(III)
mouse

Photograph of anaplastic tumor excised
injected

with

Hela

cells,

a

cervical
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A

B

C

DISCUSSION

In this study, cell lines were established from primary
human cells transfected with viral DNA constructs from two
human DNA tumor viruses,

herpes simplex virus 2 and human

papillomavirus types 16/18.

Characterization of resulting

cell lines was performed to determine if viral DNAs act in
synergy to morphologically transform primary human cells.
Human fibroblasts
analysis.

and keratinocytes were utilized

in the

Studies demonstrated that transformed cell lines

with both HSV-2 and HPV-16 or 18 had a distinct phenotype when
compared to HPV immortalized cells.
were

morphologically

distinct,

Transformed cell lines

able

to

grow

to

higher

saturation densities, exhibited anchorage independent growth
capabilities, and were able to produce lesions in athymic mice
in contrast to their HPV immortalized counterpart.

CHARACTERIZATION OF HUMAN FIBROBLAST CELL LINES.

Gingival fibroblasts were obtained from a· (1)
indi;vidual and
phenytoin,
1983) •

an

(2)

normal

from an epileptic patient treated with

anti-seizure

drug

(Delgado-Escueta

et

al.,

Phenytoin treatment of epileptic patients clearly
125
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leads to hyperplastic gingival growth (Hassel et al., 1983)
and may be related to an increased incidence of pseudolymphoma
syndrome and Hodgkin's disease
1985).

Apart

from

these

(reviewed in Wolf et al.,

observations,

little

is

known

concerning the deleterious side effects of prolonged use of
phenytoin.

Fibroblast cell lines were derived from gingival

tissue.
Early

passage

human

cells

were

cotransfected

with

plasmids containing HPV-16 and HSV-2 DNA sequences derived
from

mtr

III

or

the

H-ras

oncogene.

These

studies

demonstrated that a plasmid containing the early genes of HPV16 could efficiently immortalize gingival cells derived from
hyperplastic tissue (R-30) but not gingival cells derived from
a

normal individual

(N-16)

(Table 1).

Neither the H-ras

oncogene nor various fragments derived from HSV-2 mtr III
alone were

capable of

immortalizing R-30

or N-16

cells.

Although the HSV-2 Bgl II-C fragment is capable of fully
transforming primary Syrian hamster cells (Jariwalla et al,
1983),

it did not immortalize R-30 cells by itself.

This

suggests that requirements for immortalizing human cells are
unique with respect to primary rodent cells.

Cell lines

containing HPV-16 and H-ras or HSV-2 DNA sequences, grew more
efficiently in soft agar, had a higher saturation density, and
were more aneuploid when compared to R-30 cells or R-30 cells
immortalized by HPV-16.
The finding that HPV-16 was able to immortalize the
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hyperplastic R-30
implied

R-30

transformation.

cells more

cells
It

are
is

efficiently than N-16

predisposed
tempting

to

toward
speculate

cells

malignant
that

the

chromosomal translocation in R-30 cells and overexpression of
c-myc plays a role in efficient immortalization by HPV-16.
Southern blot analysis using two c-myc probes ( 5' -untranslated
region and a portion of exon 2) showed no major differences in
c-myc

DNA organization

(Figure

8) •

However,

c-myc

gene

expression in R-30 cells and R-30 derived cell lines was 2-3
fold higher when compared to other low passage human gingival
cell lines (N-16 or C-1) (Figure 9).

Furthermore, N-16 or C-1

cell strains do not contain obvious chromosomal aberrations.
Integration of papillomavirus sequences near the c-myc locus
has been hypothesized to play a role in viral transformation
(Durst et al., 1987) and as such c-myc appears to play a role
in HPV induced transformation.

Although c-myc is slightly

overexpressed in R-30 cells, the increased levels of c-myc was
apparently not sufficient to allow H-ras to transform R-30
cells as described using cotransfection experiments with an
activated c-mYQ and H-ras (Land et al., 1983, Parada et al.,
1984).

It is not known if the chromosomal translocation in R-

30 cells is a common result of phenytoin treatment.
appears

cellular factors

can play a

crucial

role

Thus, it
in the

efficiency of HZIP-16 induced immortalization of early passage
human cells.
All

fibroblast cell

lines cotransfected with HZIP-16
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retained HPV-16 DNA sequences as judged by Southern blotting.
Viral DNA was integrated into the cellular genome since HPV-16
sequences hybridized to the high molecular weight DNA of
genomic DNA not digested with restriction enzymes (Figures 2,
3) •

HPV-16 or 18 DNA is usually integrated in malignant

lesions in vivo (Durst et al., 1985) and in this respect, the
fibroblast

cell

lines

are

similar

to

in yiyQ findings.

Although all cell lines retained HPV-16 DNA, the number of
copies of viral DNA/cell varied dramatically among the various
cell lines.

Cell line 140 and 145 contained similar levels of

HPV-16 DNA while cell line 141 and 139 had approximately
equivalent amounts (Figure 2) suggesting a random pattern for
viral

integration

into

the

cellular

genome.

Random

integration of HPV DNA in cervical carcinoma is generally the
rule

(Durst et al.,

1983, Baker et al.,

1987).

When high

molecular weight DNA of fibroblast cell lines was analyzed to
map which regions of the HPV-16 genome were retained,
entire genome was retained.

the

The presence of multiple bands

which do not migrate with control Pst I probes

(Figure 4)

indicated integration of viral DNA with cellular DNA and
duplications of the HPV-16 genome during transformation.

As

observed

is

in

tissue

from

cervical

cancer,

HPV-16

DNA

integrated into the cellular genome in random positions and
frequently undergoes duplications or amplification (Wagatsuma
et al., 1990).
HSV-2 DNA sequences derived from mtr III were present in·
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3/3

cell

lines

cotransfected

with

HZIP-16

and

mtr

III

containing plasmids (cell lines 140, 141, and 268; Figure 6).
These results suggested retention of HSV-2 DNA sequences may
lead to growth in soft agar of transformed cells compared to
R-30 cells immortalized with HZIP-16 alone (Table 4).

HSV-2

DNA retention was not observed when Southern blotting analysis
was performed.

However, when the more sensitive PCR assay was

employed, HSV-2 mtr III specific DNA was detected, suggesting
the presence of HSV-2 DNA correlated with very low number of
viral copies.

The low copy level of HSV-2 DNA may be a result

of the excision of viral sequences during replication.

HSV-2

has been hypothesized to transform cells by a "hit and run"
mechanism

where

viral

sequences

are

required

for

transformation but not for the maintenence of the transformed
phenotype (Skinner, 1976, Galloway and McDougall, 1983).

It

is not clear if HSV-2 DNA sequences are integrated or persist
as an episome in these cells,

however,

these cells have

undergone extensive passage (at least 80 PD post geneticin
selection) prior to PCR analysis.
Several models have been proposed alluding to the role
played by tumor suppressor genes in human cancer (Knudson,
1985, stanbridge, 1990).

The E6 and E7 proteins of high risk

HPVs (types 16 and 18) interact with cellular tumor suppressor
proteins: retinoblastoma with E7 and p53 with E6.

An analysis

of HPV positive and negative cervical carcinomas revealed HPV
positive cancers had relatively low levels of hp53 protein and
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an intact hp53 gene (Scheffner et al.,
intact protein was
protein.

DNA

required to

from

fibroblast

1991) suggesting an

interact with the HPV E6
cell

lines

indicated

no

rearrangments of the hp53 gene organization when compared to
DNA from R-30 cells (Figure 10).

This result is similar to

HPV-positive carcinomas where the hp53 gene is not mutated and
thus may be able to produce an intact protein which interacts
with the HPV E6 protein.
Hyperplastic R-30 cells are a

unique model to study

multistep carcinogenesis since they do not behave as a typical
immortalized cell line.

This conclusion was based on the fact

that H-1:ll alone or HSV-2 transforming fragments were unable
to stably transform R-30 cells (Table 1).

Several studies

have demonstrated that H-ras can transform established or
immortalized cells but not primary human or rodent cells
(Sager et al., 1983, Barbacid, 1987 references therein).

When

H-ras or HSV-2 DNA fragments were cotransfected with HZIP-16,
the resulting cell

lines were distinct compared to cells

immortalized by HZIP-16.

For instance,

cotransfection of

HZIP-16 with H-ras or HSV-2 DNA sequences consistently led to
a higher degree of aneuploidy and these cells also grew better
in soft agar when compared to HZIP-16 immortalized R-30 cells
(Tables 3, 4).
Although R-30 cells are not immortalized, they may not
truly be a primary cell.

This cell strain may represent a

stage in which a cell has undergone an alteration, a "single
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hit",

which

can

phenotype.

allow

Thus,

for

subsequent

phenytoin treatment

assaults
of

R-30

on

its

cells

and

resulting hyperplasia may have resulted in the phenotypic
change of its cellular makeup which may allow for further
alterations to occur.
colorectal

cancer

Extensive genetic analysis of human

has

demonstrated

that

progression events occur during carcinoma.

multiple

tumor

There are a number

of alterations the cells undergo from activation of oncogenes
to inactivation of tumor suppressor genes (Vogelstein et al.,
1988,

Stanbridge,

1990,

Fearon and Vogelstein,

1990).

By

employing a normal primary cell strain and a primary-like cell
strain in this study, one may be able to better understand the
progression of the tumor phenotype seen in human cervical
carcinoma.

HPV-16 or 18 infection alone is not sufficient to

transform primary cells, other factors are thought to play a
role

(Broker and Botchan,

suggest

that

1986, Mccance,

immortalization

of

1986).

primary

cells

Our data
is

quite

difficult and may be facilitated by other factors or genetic
lesions.

In R-30

cells

a

chromosomal

detected between chromosomes 8 and 18.
elevated

levels

of

c-myc

compared

gingival cells (N-16 and C-1).

translocation was

These cells also had
to

other

low

passage

It is tempting to suggest

these alterations in R-30 cells allowed for more efficient
immortalization by HZIP-16.
When HSV-2
difference

in

mtr

III

phenotype

sequences were
was

present,

demonstrated

between

a

clear
HPV-16
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immortalized and HPV-16/HSV-2 transformed cell lines.

The

presence

the

of

both

viral

DNAs

clearly

enhanced

transformation phenotype of primary human cells in saturation
density values, anchorage-independent growth and aneuploidy
when compared to cell lines with HPV-16 DNA alone.

Based on

these observations, HPV-16/HSV-2 fibroblast cell lines were
more

transformed

than

HZIP-16

immortalized

cells.

The

inability to form tumors in nude mice may suggest the cells
were not completely transformed or the human cells were merely
rejected by the mouse.

It is also possible that additional

alterations may be necessary for complete transformation of
fibroblast cell lines.

For example,

tobacco use

induces

progression to invasive carcinoma in women with low grade
cervical intraepithelial neoplasia (Vessey, 1986, Trevathan et
al., 1983).
Although, a synergistic relationship is seen with HPV-16
and HSV-2 in fibroblast cell lines, another model system was
employed to verify this synergy.

HPVs are epitheliotrophic

viruses (reviewed in Broker and Botchan, 1986).
HSV-2 replicates in epithelial cells
Thus,

it

would

be

advantageous

in

Furthermore,

vivo (Roizman, 1985).

to

examine

interactions in cells of epithelial origin.

HPV/HSV-2

To achieve this

goal, genital keratinocytes were employed.

CHARACTERIZATION OF HUMAN KERATINOCYTE CELL LINES.
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To study interactions between HSV-2 and HPV-16/18

in

their natural host cell, human epithelial cells were employed.
Keratinocytes are differentiating epidermal cells and thus
these cells were utilized.

Primary genital keratinocytes were

immortalized with plasmids containing HPV-16 (FEPL) or HPV-18
(FEA) DNA seq~ences.

For analysis of keratinocyte cell lines,

HSV-2 mtr III DNA sequences were transfected into previously
HPV immortalized keratinocytes rather than cotransfected with
HPV DNA sequences.

Thus, cells were already expressing HPV

genes and expression was regulated by the LCR of the HPV
genome.

Two cell lines were used as parental cells, HPV-16

immortalized

(FEPL)

and

HPV-18

immortalized

(FEA)

cells.

Transfection analysis demonstrated that no single region of
HSV-2 mtr III was more efficient for transforming either FEPL
or FEA cells
fragment,

(Table 6)

486

TF,

suggesting the minimal transforming
was

sufficient

for

morphological

transformation of human HPV immortalized cells.
Growth characteristics of keratinocyte cell lines were
assessed. Saturation density analysis indicated FEPL or FEA
cells transformed by mtr III DNA sequences contained two times
the number of cells after one week in culture than their
immortalized counterpart

(Table

7) •

However, · cell

differed in their ability to grow in soft agar.

lines

Neither FEA

cells nor transformed derivatives were able to grow in 0.3%
agar.

In contrast,

FEPL transformed cells grew with high

efficiency in soft agar (Table 7).

Immortalized FEPL cells
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also grew in 0.3% agar, however not with the efficiency of
their transformed counterpart.

The inability of FEA cells to

exhibit anchorage independent growth suggested these cells may
not

be

fully

transformed

compared

to

FEPL

transformed

derivatives.
Many studies have established a role for the activation
of oncogenes such as c-myc and the inactivation of tumor
suppressor genes, p53, in carcinomas (Riou et al., 1987, Crook
et al., 1990, Schaffner et al., 1991).

We wanted to examine

if these genes were altered in the keratinocyte cell lines.
Southern blot analysis of DNA from transformed cell lines
hybridized to two c-myc probes showed no alterations in this
gene when compared to immortalized keratinocytes (Figures 22,
23).

Furthermore, no detectable alterations of the hp53 gene

were observed in transformed cells (Figures 24, 25).

This

data suggested that alterations of the hp53 or c-myc genes
were not required for transformation of keratinocyte cell
lines.
Analysis of HPV DNA organization of transf armed cell
lines was performed to determine if rearrangments of the HPV
DNA occurred.

FEPL cells contained 3. 4 kb of the HPV-16

genome which encompasses the LCR, ORFs E6, E7 and subregions
of El and Ll (Kaur et al., 1989). Integration of HPV-16 DNA
sequences into the cellular genome seldom disrupts the LCR, E6
and E7 ORFs (Matsukura et al., 1986, Pater and Pater, 1985,
Seedorf

et

al.,

1987)

since

these

are

necessary

for
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immortalization.

In cells obtained from cervical carcinomas

the integration site of HPV DNA is frequently within E2 (Durst
et al., 1986, Matsukura et al., 1986, Pater and Pater, 1985).
The integration event usually disrupts E2.

Since FEPL cells

contain just the HPV-16 sequences which are required for
immortalization, it was not surprising that rearrangments of
HPV DNA were not detected in the HSV-2 transformed cells.
FEA transformed derivatives were also analyzed to examine
HPV-18 DNA organization.

FEA cells contain the entire genome

of HPV-18, 7.9 kb DNA (Kaur and McDougall, 1988).

When high

molecular weight DNA was hybridized with a probe spanning the
entire 7.9 kb genome of HPV-18, rearrangments of HPV DNA in
. cells transformed by HSV-2 was detected when compared to
immortalized cells (Figures 17, 18) • However, no changes were
detected when DNA was probed with a HPV-18 probe spanning the
LCR, E6 and E7 regions (Figure 19).

This was predictable

since expression of E6 and E7 is required for maintaining an
immortalized state.

Specific recombination between HSV-2 and

HPV-18 may not occur since rearrangments of HPV-18 DNA also
occurred in cell line A-ras (Figure 18, lane H), FEA cells
transfected

with

H-ras.

Rearrangements

in

HPV-18

DNA

sequences in FEA transformed cell lines may suggest that the
presence of the entire genome of HPV-18 provides a greater
region available for recombination between the two DNAs in
contrast to FEPL cells containing only 3.4 kb HPV-16 DNA.
The retention of HSV-2 DNA sequences in transformed cells
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is inconsistent (reviewed by MacNab, 1987).

However evidence

has demonstrated a correlation between HSV-2 infection and
cervical carcinoma (DiLuca et al., 1989, Hildesheim et al.,
1991). Thus, keratinocyte cell lines were examined to detect
the retention of HSV-2 sequences.

Southern blot analysis

failed to detect HSV-2 mtr III sequences.

When PCR analysis

was utilized to detect HSV-2 sequences in transformed cells,
not

all

of the

(Figure 21).

cell

lines

contained HSV-2

DNA sequences

In fact, analysis of FEPL and FEA transformed

derivatives indicated HSV-2 retention in only 3/5 HPV-18/HSV-2
cell lines and 0/5 HPV-16/HSV-2 cell lines.

since all cell

lines do not retain HSV-2 DNA, retention is not required for
maintenence of the transformed phenotype.

Conversely, only

small portions of HSV-2 DNA are retained in transformed cell
since HSV-2 is known to excise itself and portions of the
cellular genome (Jariwalla et al., 1986).

This random nature

of HSV-2 retention in keratinocyte cell lines seems to confirm
the hypothesis that HSV-2 DNA sequences are required for the
initiation of transformation but not the maintenance of the
transformed state

(Skinner,

1983).

After HSV-2

behaved

distinctly

from

though,

HSV-2

was

DNA

1976,

transfection,

Galloway and McDougall,
transformed cell

immortalized
not

detected

counterparts,
in

all

lines
even

transformed

derivatives.
The tumorigenic potential of FEA and FEPL cell lines was
examined by injecting respective cell lines subcutaneously
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into

nude

mice.

FEA

cells,

immortalized

as

transformed, were unable to produce any tumors.

well

as

Tumor-like

lesions were not detected even with FEA cells transfected with
H-ras.

In contrast, all FEPL transformed derivatives were

able to form abnormal epithelial lesions (Table 8) •

FEPL

cells transfected with H-ras were not invasive as Matlashewski
et al., (1987) had demonstrated previously with rodent cells.
This may suggest that human cells are more refractile to
tumorigenic conversion when compared to rodent cells.

Tumor-

like lesions were present when HSV-2 transformed FEPL cells
were injected into nu/,ny mice but not with FEPL cells.

It can

be implied that alterations have occurred in transformed FEPL
cells and the initial stages of the transformed phenotype are
being exhibited.
When the tumor-like lesions were examined by histological
methods, they were identified as benign cysts.

If cells from

an invasive cervical carcinoma (Hela) were injected into nu/nu
mice, large metastatic tumors developed.

The size of the FEPL

epithelial cyst was quite small, 3-5 mm in size (Figure 27),
whereas, the Hela tumor grew to more than 20 times this size
(Figure 29).

Both epithelial lesions and Hela tumors were

solid masses and thus difficult to dissect.

small nodules

were also detected in immortalized FEPL cells 1-2 weeks post
injection.

However,

these small nodules regressed.

In

contrast, when FEPL transformed cells were injected into nu/nu
mice, tumor-like lesions appeared 2-3 weeks post injection and
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remained up to 8 weeks with slow continous growth.

When Hela

cells were injected into mice, 1 week post injection, several
tumors

developed

near

the

site

of

injection

which

grew

rapidly. Histological analysis demonstrated differences among
lesions.

With the Hela tumor, numerous multinucleated cells,

abnormal mitotic phases were visible along with necrotic cells
near the tumor (Figure 28) indicative of anaplastic carcinoma.
In

contrast,

the

tumor-like

lesion

induced

transformed cells were a keratinized cyst.

by

HSV-2

The cyst contained

actively growing cells which enlarged the lesion with time.
These results demonstrated that FEPL cells transformed by HSV2 fragments derived from mtr III were able to form small
benign tumors or cysts in nu/DY mice.
The mechanism by which a cell progresses to the malignant
phenotype after HPV-16 infection in vivo is not known.

The

presence of HPV-16 or HPV-18 alone is not sufficient for
tumorigenesis

(reviewed

Additional cofactors,

in

Broker

environmental

and

Botchan,

or viral,

crucial role in tumor progression events.

1986).

may play a

Since HSV-2 is

transmitted sexually similar to HPVs, infects the same cells
as

HPVs,

and

can

induce

morphological

transformation,

progression may be mediated by this virus (zur Hausen, 1983).
studies assessing a posssible synergy between HSV-2 and highrisk HPV infections in the pathology of cervical carcinoma
have looked for the presence of both viral DNAs in tumor
tissue.

Molecular analysis of HPV-16 and HSV-2 demonstrated
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that 30% of cervical cancer tissues had homology to HSV-2 mtr
II

and

mtr

III

sequences

(DiLuca

et

al.,

1989) •

Seroepidemiological studies have demonstrated an etiologic
role for HSV-2 in the development of cervical cancer where
women

with

cervical

cancer

have

antibodies compared to controls

higher

levels

of

(Kaufman and Adam,

HSV-2
1986).

Women that are HSV-2 seropositive and infected with HPV-16/18
have a

60% increased risk of cervical cancer compared to

seronegative women infected with HPV-16/18 (Hildesheim et al.,
1991).
that

These studies provide further evidence to the role

HSV-2

plays

in conjunction with high-risk HPVs,

in

cervical carcinoma.
In our analysis, we have demonstrated the synergistic
role

played

by HSV-2

and HPV-16/18

transformation of primary human cells.

in the morphological
Characterization of

human cell lines immortalized by HPV-16/18 have a distinct
phenotype compared to cells transformed by HPV-16/18 and HSV-2
DNA sequences.

The development of tumor-like lesions by

transformed HPV-16/HSV-2 keratinocytes and not by immortalized
HPV-16 cells suggests transfection of HSV-2 sequences may have
altered these cells and led to enhanced invasive properties.
HSV-2 is known to induce stable heritable changes in the cell
without the need for viral replication or gene expression
(Clarke and Clements, 1991).
been

already

altered

by

Thus, in FEPL cells which have
immortalization,

the

mutagenic

abilities of HSV-2 could induce alterations in cellular DNA
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and subsequently lead to the transformed phenotype.
However, FEA cells containing the entire genome of HPV-18
did not produce any lesions in mice even though J/5 cell lines
retained HSV-2 DNA sequences and transformed cell lines had
HPV-18 DNA rearranged.

It may be speculated that several

factors have a role in the inability of these lesions to
produce tumors.

FEA cells with the complete HPV-18 genome can

express the E2 protein which acts as a

transacti vator or

repressor of HPV gene expression (Phelps and Howley, 1987,
Cripe et al., 1987).
transactivate

Full-length E2 binds to Spl sites to

transcription

whereas

a

truncated

E2

will

repress transcription (Li et al., 1991, Cripe et al., 1987).
Thus, if rearrangments within the HPV-18 genome altered the E2
gene, truncated E2 proteins may act not only on the HPV-18 LCR
but also on the promoters of HSV-2 mtr III sequences (Jones,
1989) to down regulate transcription.
HPV-16/18

DNAs

are

associated

with

the

majority

of

cervical carcinomas, the viral DNA can be detected in at least
85% of cervical carcinoma biopsies (Broker and Botchan, 1986).
Of

these,

positive

HPV-16
cervical

accounts

for

carcinomas

approximately
while

HPV-18

60%

of

HPV

accounts

for

approximately 10-15% (Villa and Schlegel, 1991).

The reason

for the prevelance of HPV-16 in cervical carcinoma and not
HPV-18 is not known.

No significant differences have been

found between E6 and E7 proteins of types 16 and 18, nor was
there any major disparity in the LCRs of both viruses (Villa
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and Schlegel, 1991).

It may be that HSV-2 interacts with HPV-

16 to produce a malignant phenotype but cannot carry out the
same interactions with HPV-18.
In our analysis,
cell

lines

the characterization of keratinocyte

imply that HSV-2

can

interact with HPV-16

to

produce cells with a transformed phenotype but it is not able
to do so with HPV-18.

Data also suggests that HSV-2 can act

as a cofactor with HPV-16 to transform primary human cells.
Premalignant papillomavirus lesions in a

number of animal

models progress to malignancy after interacting with other
known mutagens (Jarrett et al., 1980, Rous and Kidd, 1938,
Orth et al.,

1978).

HSV-2,

with its ability to act as a

biological mutagen, is a biologically relevant cofactor in the
development of genital cancer.
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